Link to all Central Africa Publications in PubMed
2775998
ZVWK2Q45
2023
items
1
0
date
desc
year
257
https://www.iedea.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-49adc6fd5699bd37050d6e3696745fc8%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22XLBPKKGG%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zotova%20et%20al.%22%2C%22parsedDate%22%3A%222023-10-23%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EZotova%2C%20Natalia%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMunyaneza%2C%20Athanase%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMurenzi%2C%20Gad%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKubwimana%2C%20Gallican%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAdedimeji%2C%20Adebola%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20Low%20birth%20weight%20among%20infants%20and%20pregnancy%20outcomes%20among%20women%20living%20with%20HIV%20and%20HIV-negative%20women%20in%20Rwanda.%20%3Ci%3EResearch%20Square%3C%5C%2Fi%3E%2C%20S.%20rs.3.rs-3467879.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21203%5C%2Frs.3.rs-3467879%5C%2Fv1%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21203%5C%2Frs.3.rs-3467879%5C%2Fv1%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Low%20birth%20weight%20among%20infants%20and%20pregnancy%20outcomes%20among%20women%20living%20with%20HIV%20and%20HIV-negative%20women%20in%20Rwanda%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Natalia%22%2C%22lastName%22%3A%22Zotova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Athanase%22%2C%22lastName%22%3A%22Munyaneza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gallican%22%2C%22lastName%22%3A%22Kubwimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ca-IeDEA%22%2C%22lastName%22%3A%22Ca-IeDEA%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20In%20utero%20exposure%20to%20HIV%20and%5C%2For%20triple%20antiretroviral%20therapy%20%28ART%29%20have%20been%20shown%20to%20be%20associated%20with%20preterm%20births%20and%20low%20birth%20weight%20%28LBW%29%2C%20but%20data%20from%20low-resources%20settings%20with%20high%20burden%20of%20HIV%20remain%20limited.%20This%20study%20utilized%20retrospective%20data%20to%20describe%20pregnancy%20outcomes%20among%20Rwandan%20women%20living%20with%20HIV%20%28WLHIV%29%20and%20HIV-negative%20women%20and%20to%20assess%20the%20association%20of%20HIV%20and%20ART%20with%20LBW.%5CnMETHODS%3A%20This%20study%20used%20data%20from%20a%20large%20cohort%20of%20WLHIV%20and%20HIV-negative%20women%20in%20Rwanda%20for%20a%20cross-sectional%20analysis.%20Retrospective%20data%20were%20collected%20from%20antenatal%20care%20%28ANC%29%2C%20delivery%2C%20and%20Prevention%20of%20Mother%20to%20Child%20Transmission%20%28PMTCT%29%20registries%20within%20the%20Central%20Africa%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28CA-IeDEA%29%20in%20Rwanda.%20Data%20from%20women%20with%20documented%20HIV%20test%20results%20and%20known%20pregnancy%20outcomes%20were%20included%20in%20the%20analysis.%20Analyses%20for%20predictors%20of%20LBW%20%28%3C%202%2C500%20g%29%20were%20restricted%20to%20singleton%20live%20births.%20Logistic%20models%20were%20used%20to%20identify%20independent%20predictors%20and%20estimate%20the%20odd%20ratios%20%28OR%29%20and%2095%25%20confidence%20intervals%20%28CI%29%20measuring%20the%20strength%20of%20their%20association%20with%20LBW.%5CnRESULTS%20AND%20DISCUSSION%3A%20Out%20of%2010%2C608%20women%20with%20known%20HIV%20status%20and%20with%20documented%20pregnancy%20outcomes%2C%209.7%25%20%28n%20%3D%201%2C024%29%20were%20WLHIV.%20We%20restricted%20the%20sample%20to%2010%2C483%20women%20who%20had%20singleton%20live%20births%20for%20the%20analysis%20of%20the%20primary%20outcome%2C%20LBW.%20Compared%20with%20HIV-negative%20women%2C%20WLHIV%20had%20higher%20rates%20of%20stillbirth%2C%20preterm%20births%2C%20and%20LBW%20babies.%20Multivariable%20model%20showed%20that%20WLHIV%20and%20primigravidae%20had%20higher%20odds%20of%20LBW.%20Lower%20maternal%20weight%20and%20primigravidae%20status%20were%20associated%20with%20greater%20odds%20of%20LBW.%20Among%20WLHIV%2C%20the%20use%20of%20ART%20was%20associated%20with%20significantly%20lower%20odds%20of%20LBW%20in%20a%20bivariate%20analysis.%20Even%20in%20a%20sample%20of%20relatively%20healthier%20uncomplicated%20pregnancies%20and%20women%20who%20delivered%20in%20low-risk%20settings%2C%20WLHIV%20still%20had%20higher%20rates%20of%20poor%20pregnancy%20outcomes%20and%20to%20have%20LBW%20infants%20compared%20to%20women%20without%20HIV.%20Lower%20maternal%20weight%20and%20primigravidae%20status%20were%20independently%20associated%20with%20LBW.%20Given%20that%20supplementary%20nutrition%20to%20malnourished%20pregnant%20women%20is%20known%20to%20decrease%20the%20incidence%20of%20LBW%2C%20providing%20such%20supplements%20to%20lower-weight%20WLHIV%2C%20especially%20primigravidae%20women%2C%20might%20help%20reduce%20LBW.%22%2C%22date%22%3A%222023-10-23%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.21203%5C%2Frs.3.rs-3467879%5C%2Fv1%22%2C%22ISSN%22%3A%22%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22369YB7BV%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222023-12-01T10%3A44%3A16Z%22%7D%7D%2C%7B%22key%22%3A%22I4UVBT6Y%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ingabire%20et%20al.%22%2C%22parsedDate%22%3A%222023-09-19%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EIngabire%2C%20Charles%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EWatnick%2C%20Dana%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EGasana%2C%20Josephine%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EUmwiza%2C%20Francine%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMunyaneza%2C%20Athanase%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20Experiences%20of%20stigma%20and%20HIV%20care%20engagement%20in%20the%20context%20of%20Treat%20All%20in%20Rwanda%3A%20a%20qualitative%20study.%20%3Ci%3EBMC%20Public%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E23%3C%5C%2Fi%3E%20%281%29%2C%20S.%201817.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12889-023-16752-y%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12889-023-16752-y%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Experiences%20of%20stigma%20and%20HIV%20care%20engagement%20in%20the%20context%20of%20Treat%20All%20in%20Rwanda%3A%20a%20qualitative%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%22%2C%22lastName%22%3A%22Ingabire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dana%22%2C%22lastName%22%3A%22Watnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Josephine%22%2C%22lastName%22%3A%22Gasana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francine%22%2C%22lastName%22%3A%22Umwiza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Athanase%22%2C%22lastName%22%3A%22Munyaneza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gallican%22%2C%22lastName%22%3A%22Kubwimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gad%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adebola%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Ross%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20%27Treat%20All%27%20policies%20recommending%20immediate%20antiretroviral%20therapy%20%28ART%29%20soon%20after%20HIV%20diagnosis%20for%20all%20people%20living%20with%20HIV%20%28PLHIV%29%20are%20now%20ubiquitous%20in%20sub-Saharan%20Africa.%20While%20early%20ART%20initiation%20and%20retention%20is%20effective%20at%20curtailing%20disease%20progression%20and%20transmission%2C%20evidence%20suggests%20that%20stigma%20may%20act%20as%20a%20barrier%20to%20engagement%20in%20care.%20This%20study%20sought%20to%20understand%20the%20relationships%20between%20HIV%20stigma%20and%20engagement%20in%20care%20for%20PLHIV%20in%20Rwanda%20in%20the%20context%20of%20Treat%20All.%5CnMETHODS%3A%20Between%20September%202018%20and%20March%202019%2C%20we%20conducted%20semi-structured%2C%20qualitative%20interviews%20with%20adult%20PLHIV%20receiving%20care%20at%20two%20health%20centers%20in%20Kigali%2C%20Rwanda.%20We%20used%20a%20grounded%20theory%20approach%20to%20data%20analysis%20to%20develop%20conceptual%20framework%20describing%20how%20stigma%20influences%20HIV%20care%20engagement%20in%20the%20context%20of%20early%20Treat%20All%20policy%20implementation%20in%20Rwanda.%5CnRESULTS%3A%20Among%2037%20participants%2C%2027%20%2873%25%29%20were%20women%20and%20the%20median%20age%20was%2031%5Cu00a0years.%20Participants%20described%20how%20care%20engagement%20under%20Treat%20All%2C%20including%20taking%20medications%20and%20attending%20appointments%2C%20increased%20their%20visibility%20as%20PLHIV.%20This%20served%20to%20normalize%20HIV%20and%20use%20of%20ART%20but%20also%20led%20to%20high%20levels%20of%20anticipated%20stigma%20in%20the%20health%20center%20and%20community%20at%20early%20stages%20of%20treatment.%20Enacted%20stigma%20from%20family%20and%20community%20members%20and%20resultant%20internalized%20stigma%20acted%20as%20additional%20barriers%20to%20care%20engagement.%20Nonetheless%2C%20participants%20described%20how%20psychosocial%20support%20from%20care%20providers%20and%20family%20members%20helped%20them%20cope%20with%20stigma%20and%20promoted%20continued%20engagement%20in%20care.%5CnCONCLUSIONS%3A%20Treat%20All%20policy%20in%20Rwanda%20has%20heightened%20the%20visibility%20of%20HIV%20at%20the%20individual%20and%20social%20levels%2C%20which%20has%20influenced%20HIV%20stigma%2C%20normalization%2C%20psychosocial%20support%20and%20care%20engagement%20in%20complex%20ways.%20Leveraging%20the%20individual%20and%20community%20support%20described%20by%20PLHIV%20to%20deliver%20evidence-based%2C%20peer%20or%20provider-delivered%20stigma%20reduction%20interventions%20may%20aid%20in%20attaining%20Treat%20All%20goals.%22%2C%22date%22%3A%222023-09-19%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12889-023-16752-y%22%2C%22ISSN%22%3A%221471-2458%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222023-10-10T11%3A49%3A00Z%22%7D%7D%2C%7B%22key%22%3A%22NSA73LXB%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nachega%20et%20al.%22%2C%22parsedDate%22%3A%222023-09%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ENachega%2C%20Jean%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMusoke%2C%20Philippa%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKilmarx%2C%20Peter%20H.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EGandhi%2C%20Monica%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EGrinsztejn%2C%20Beatriz%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20Global%20HIV%20control%3A%20is%20the%20glass%20half%20empty%20or%20half%20full%3F%20%3Ci%3EThe%20Lancet.%20HIV%3C%5C%2Fi%3E%2C%20%3Ci%3E10%3C%5C%2Fi%3E%20%289%29%2C%20S.%20e617%26%23x2013%3Be622.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2352-3018%2823%2900150-9%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2352-3018%2823%2900150-9%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20HIV%20control%3A%20is%20the%20glass%20half%20empty%20or%20half%20full%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20B.%22%2C%22lastName%22%3A%22Nachega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippa%22%2C%22lastName%22%3A%22Musoke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20H.%22%2C%22lastName%22%3A%22Kilmarx%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Monica%22%2C%22lastName%22%3A%22Gandhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Beatriz%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anton%22%2C%22lastName%22%3A%22Pozniak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angeli%22%2C%22lastName%22%3A%22Rawat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lindsay%22%2C%22lastName%22%3A%22Wilson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20J.%22%2C%22lastName%22%3A%22Mills%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frederick%20L.%22%2C%22lastName%22%3A%22Altice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20W.%22%2C%22lastName%22%3A%22Mellors%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20C.%22%2C%22lastName%22%3A%22Quinn%22%7D%5D%2C%22abstractNote%22%3A%22The%20massive%20scale-up%20of%20HIV%20treatment%20and%20prevention%20over%20the%20past%20two%20decades%20has%20resulted%20in%20important%20reductions%20in%20new%20infections%20and%20mortality%20globally.%20Reduction%20in%20HIV%20incidence%2C%20however%2C%20has%20been%20unequal%2C%20with%20worsening%20epidemics%20in%20regions%20where%20the%20reach%20and%20scale%20of%20HIV%20control%20programmes%20have%20been%20insufficient%2C%20especially%20in%20eastern%20Europe%2C%20central%20Asia%2C%20the%20Middle%20East%2C%20north%20Africa%2C%20and%20Latin%20America%20where%20HIV%20epidemics%20are%20concentrated%20among%20key%20populations%2C%20including%20people%20who%20inject%20drugs%2C%20men%20who%20have%20sex%20with%20men%2C%20transgender%20people%2C%20and%20some%20minority%20racial%20and%20ethnic%20groups.%20The%20global%20state%20of%20the%20HIV%20pandemic%20highlights%20disparities%20in%20HIV%20control%20efforts%20and%20provides%20a%20roadmap%20for%20what%20should%20be%20done%2C%20including%20investment%20to%20better%20implement%20the%20effective%20HIV%20prevention%20and%20treatment%20tools%20that%20are%20available%2C%20but%20whose%20adoption%20and%20scale-up%20are%20not%20yet%20sufficient%20to%20get%20us%20close%20to%20an%20AIDS-free%20generation.%20To%20achieve%20the%20full%20potential%20of%20global%20HIV%20control%2C%20we%20call%20for%20urgent%2C%20evidence-informed%20implementation%20at%20scale%20of%20our%20existing%20and%20novel%20HIV%20prevention%20and%20treatment%20strategies%20in%20ways%20that%20are%20better%2C%20faster%2C%20more%20efficient%2C%20and%20cost-effective%2C%20especially%20in%20key%20populations%20and%20regions%20where%20the%20HIV%20pandemic%20continues%20to%20expand.%22%2C%22date%22%3A%222023-09%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3018%2823%2900150-9%22%2C%22ISSN%22%3A%222352-3018%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222023-10-10T11%3A50%3A15Z%22%7D%7D%2C%7B%22key%22%3A%22NY835Y2R%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222023-08%22%2C%22numChildren%22%3A10%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EParcesepe%2C%20Angela%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EStockton%2C%20Melissa%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERemch%2C%20Molly%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EWester%2C%20C.%20William%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBernard%2C%20Charlotte%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20Availability%20of%20screening%20and%20treatment%20for%20common%20mental%20disorders%20in%20HIV%20clinic%20settings%3A%20data%20from%20the%20global%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Consortium%2C%202016-2017%20and%202020.%20%3Ci%3EJournal%20of%20the%20International%20AIDS%20Society%3C%5C%2Fi%3E%2C%20%3Ci%3E26%3C%5C%2Fi%3E%20%288%29%2C%20S.%20e26147.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26147%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26147%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Availability%20of%20screening%20and%20treatment%20for%20common%20mental%20disorders%20in%20HIV%20clinic%20settings%3A%20data%20from%20the%20global%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Consortium%2C%202016-2017%20and%202020%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Angela%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Stockton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Molly%22%2C%22lastName%22%3A%22Remch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20William%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeremy%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andreas%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rogers%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keri%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22William%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Albert%22%2C%22lastName%22%3A%22Minga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edith%22%2C%22lastName%22%3A%22Kwobah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mpho%22%2C%22lastName%22%3A%22Tlali%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junko%22%2C%22lastName%22%3A%22Tanuma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dominique%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aimee%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Denis%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20Consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Common%20mental%20disorders%20%28CMDs%29%20are%20highly%20prevalent%20among%20people%20with%20HIV.%20Integrating%20mental%20healthcare%20into%20HIV%20care%20may%20improve%20mental%20health%20and%20HIV%20treatment%20outcomes.%20We%20describe%20the%20reported%20availability%20of%20screening%20and%20treatment%20for%20depression%2C%20anxiety%20and%20post-traumatic%20stress%20disorder%20%28PTSD%29%20at%20global%20HIV%20treatment%20centres%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Consortium%20in%202020%20and%20changes%20in%20availability%20at%20sites%20in%20low-%20or%20middle-income%20countries%20%28LMICs%29%20between%202016%5C%2F2017%20and%202020.%5CnMETHODS%3A%20In%202020%2C%20238%20sites%20contributing%20individual-level%20data%20to%20the%20IeDEA%20Consortium%20and%20in%202016%5C%2F2017%20a%20stratified%20random%20sample%20of%20IeDEA%20sites%20in%20LMICs%20were%20eligible%20to%20participate%20in%20site%20surveys%20on%20the%20availability%20of%20screening%20and%20treatment%20for%20CMDs.%20We%20assessed%20trends%20over%20time%20for%2068%20sites%20across%2027%20LMICs%20that%20participated%20in%20both%20surveys.%5CnRESULTS%3A%20Among%20the%20238%20sites%20eligible%20to%20participate%20in%20the%202020%20site%20survey%2C%20227%20%2895%25%29%20participated%2C%20and%20mental%20health%20screening%20and%20treatment%20data%20were%20available%20for%20223%20%2898%25%29%20sites%20across%2041%20countries.%20A%20total%20of%2095%20sites%20across%2029%20LMICs%20completed%20the%202016%5C%2F2017%20survey.%20In%202020%2C%2068%25%20of%20sites%20were%20in%20urban%20settings%2C%20and%2077%25%20were%20in%20LMICs.%20Overall%2C%2050%25%2C%2014%25%20and%2012%25%20of%20sites%20reported%20screening%20with%20a%20validated%20instrument%20for%20depression%2C%20anxiety%20and%20PTSD%2C%20respectively.%20Screening%20plus%20treatment%20in%20the%20form%20of%20counselling%20was%20available%20for%20depression%2C%20anxiety%20and%20PTSD%20at%2046%25%2C%2013%25%20and%2011%25%20of%20sites%2C%20respectively.%20Screening%20plus%20treatment%20in%20the%20form%20of%20medication%20was%20available%20for%20depression%2C%20anxiety%20and%20PTSD%20at%2036%25%2C%2011%25%20and%208%25%20of%20sites%2C%20respectively.%20Among%20sites%20that%20participated%20in%20both%20surveys%2C%20screening%20for%20depression%20was%20more%20commonly%20available%20in%202020%20than%202016%5C%2F2017%20%2875%25%20vs.%2059%25%2C%20respectively%2C%20p%20%3D%200.048%29.%5CnCONCLUSIONS%3A%20Reported%20availability%20of%20screening%20for%20depression%20increased%20among%20this%20group%20of%20IeDEA%20sites%20in%20LMICs%20between%202016%5C%2F2017%20and%202020.%20However%2C%20substantial%20gaps%20persist%20in%20the%20availability%20of%20mental%20healthcare%20at%20HIV%20treatment%20sites%20across%20global%20settings%2C%20particularly%20in%20resource-constrained%20settings.%20Implementation%20of%20sustainable%20strategies%20to%20integrate%20mental%20health%20services%20into%20HIV%20care%20is%20needed.%22%2C%22date%22%3A%222023-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26147%22%2C%22ISSN%22%3A%221758-2652%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-11-08T10%3A06%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22L8YKFKT6%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chiarappa%20et%20al.%22%2C%22parsedDate%22%3A%222023-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EChiarappa%2C%20Joseph%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EHoover%2C%20Donald%20R.%3C%5C%2Fspan%3E%20%26amp%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EPedley%2C%20Alison%3C%5C%2Fspan%3E%20%282023%29.%20Economizing%20comparative%20Poisson%20clinical%20trials%20of%20multiple%20experimental%20treatments%20by%20testing%20against%20the%20same%20control.%20%3Ci%3EStatistical%20Methods%20in%20Medical%20Research%3C%5C%2Fi%3E%2C%20%3Ci%3E32%3C%5C%2Fi%3E%20%288%29%2C%20S.%201604%26%23x2013%3B1615.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F09622802231181235%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1177%5C%2F09622802231181235%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Economizing%20comparative%20Poisson%20clinical%20trials%20of%20multiple%20experimental%20treatments%20by%20testing%20against%20the%20same%20control%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20A.%22%2C%22lastName%22%3A%22Chiarappa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%20R.%22%2C%22lastName%22%3A%22Hoover%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alison%22%2C%22lastName%22%3A%22Pedley%22%7D%5D%2C%22abstractNote%22%3A%22Comparative%20Poisson%20trials%20of%20an%20experimental%20treatment%20versus%20a%20control%20typically%20condition%20on%20the%20total%20number%20of%20events%20that%20occur%20across%20both%20arms%20%28Design%20A%29.%20Inference%20is%20based%20on%20the%20binomial%20distribution.%20Recently%2C%20an%20approach%20termed%20Design%20C%20to%20compare%20K%20experimental%20treatments%20to%20the%20same%20control%20was%20introduced.%20Under%20Design%20C%20without%20curtailment%2C%20the%20trial%20continues%20until%20a%20prespecified%20number%20of%20events%20occur%20in%20the%20control%20arm%2C%20leading%20to%20inference%20based%20on%20the%20negative%20multinomial%20distribution.%20The%20question%20remains%20of%20how%20advantageous%20it%20is%20to%20conduct%20one%20Design%20C%20trial%20comparing%20K%20experimental%20treatment%20arms%20to%20the%20same%20control%20arm%20as%20opposed%20to%20conducting%20K%20separate%20Design%20A%20trials%20each%20comparing%20one%20experimental%20treatment%20arm%20to%20a%20different%20control%20arm.%20This%20paper%2C%20therefore%2C%20compares%20the%20expected%20number%20of%20subjects%20to%20enroll%20for%20the%20two%20designs%20under%20uncurtailed%20and%20curtailed%20settings.%20The%20designs%20are%20evaluated%20when%20the%20null%20hypothesis%20and%20various%20assumptions%20for%20the%20alternative%20hypothesis%20hold.%20We%20simulate%20a%20variety%20of%20combinations%20for%20the%20Type%201%20error%2C%20power%2C%20and%20ratio%20of%20the%20incidence%20rate%20of%20events%20in%20the%20experimental%20treatment%20to%20control%20arms.%20Design%20C%20frequently%20offers%20significant%20savings%20in%20terms%20of%20sample%20size%20relative%20to%20Design%20A.%22%2C%22date%22%3A%222023-08%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1177%5C%2F09622802231181235%22%2C%22ISSN%22%3A%221477-0334%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222023-10-10T11%3A51%3A20Z%22%7D%7D%2C%7B%22key%22%3A%22CPLBD3LZ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222023-07%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EParcesepe%2C%20A.%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFiliatreau%2C%20L.%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EGomez%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEbasone%2C%20P.%20V.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EDzudie%2C%20A.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20Coping%20Strategies%20and%20Symptoms%20of%20Mental%20Health%20Disorders%20Among%20People%20with%20HIV%20Initiating%20HIV%20Care%20in%20Cameroon.%20%3Ci%3EAIDS%20Behav%3C%5C%2Fi%3E%2C%20%3Ci%3E27%3C%5C%2Fi%3E%20%287%29%2C%20S.%202360%26%23x2013%3B2369.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10461-022-03963-4%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10461-022-03963-4%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Coping%20Strategies%20and%20Symptoms%20of%20Mental%20Health%20Disorders%20Among%20People%20with%20HIV%20Initiating%20HIV%20Care%20in%20Cameroon%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20M.%22%2C%22lastName%22%3A%22Filiatreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20V.%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Dzudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20W.%22%2C%22lastName%22%3A%22Pence%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Wainberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Pefura-Yone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nsame%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22Little%20is%20known%20about%20the%20coping%20strategies%20used%20among%20people%20with%20HIV%20%28PWH%29%2C%20especially%20in%20sub-Saharan%20Africa%2C%20and%20the%20extent%20to%20which%20adaptive%20or%20maladaptive%20coping%20strategies%20are%20associated%20with%20symptoms%20of%20mental%20health%20disorders.%20We%20interviewed%20426%20PWH%20initiating%20HIV%20care%20in%20Cameroon%20and%20reported%20the%20prevalence%20of%20adaptive%20and%20maladaptive%20coping%20strategies%2C%20overall%20and%20by%20presence%20of%20symptoms%20of%20depression%2C%20anxiety%2C%20and%20PTSD.%20Log%20binominal%20regression%20was%20used%20to%20estimate%20the%20association%20between%20each%20type%20of%20coping%20strategy%20%28adaptive%20or%20maladaptive%29%20and%20symptoms%20of%20each%20mental%20health%20disorder%2C%20separately.%20Adaptive%20and%20maladaptive%20coping%20strategies%20were%20commonly%20reported%20among%20PWH%20enrolling%20in%20HIV%20care%20in%20Cameroon.%20Across%20all%20mental%20health%20disorders%20assessed%2C%20greater%20maladaptive%20coping%20was%20associated%20with%20higher%20prevalence%20of%20depression%2C%20anxiety%2C%20and%20PTSD.%20Adaptive%20coping%20was%20not%20associated%20with%20symptoms%20of%20any%20of%20the%20mental%20health%20disorders%20assessed%20in%20bivariate%20or%20multivariable%20models.%20Our%20study%20found%20that%20PWH%20endorsed%20a%20range%20of%20concurrent%20adaptive%20and%20maladaptive%20coping%20strategies.%20Future%20efforts%20should%20explore%20the%20extent%20to%20which%20coping%20strategies%20change%20throughout%20the%20HIV%20care%20continuum.%20Interventions%20to%20reduce%20maladaptive%20coping%20have%20the%20potential%20to%20improve%20the%20mental%20health%20of%20PWH%20in%20Cameroon.%22%2C%22date%22%3A%22Jul%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10461-022-03963-4%22%2C%22ISSN%22%3A%221573-3254%20%28Electronic%29%201090-7165%20%28Print%29%201090-7165%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A06%3A44Z%22%7D%7D%2C%7B%22key%22%3A%224I6XHRSC%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nachega%20et%20al.%22%2C%22parsedDate%22%3A%222023-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ENachega%2C%20J.%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ENsanzimana%2C%20S.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERawat%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EWilson%2C%20L.%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERosenthal%2C%20P.%20J.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20Advancing%20detection%20and%20response%20capacities%20for%20emerging%20and%20re-emerging%20pathogens%20in%20Africa.%20%3Ci%3ELancet%20Infect%20Dis%3C%5C%2Fi%3E%2C%20%3Ci%3E23%3C%5C%2Fi%3E%20%285%29%2C%20S.%20e185%26%23x2013%3Be189.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2822%2900723-X%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2822%2900723-X%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Advancing%20detection%20and%20response%20capacities%20for%20emerging%20and%20re-emerging%20pathogens%20in%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20B.%22%2C%22lastName%22%3A%22Nachega%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Nsanzimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Rawat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20A.%22%2C%22lastName%22%3A%22Wilson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20J.%22%2C%22lastName%22%3A%22Rosenthal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20J.%22%2C%22lastName%22%3A%22Siedner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20K.%22%2C%22lastName%22%3A%22Varma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20H.%22%2C%22lastName%22%3A%22Kilmarx%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Mutesa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Tanner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Binagwaho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Forrest%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Mbala-Kingebeni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20J.%22%2C%22lastName%22%3A%22Muyembe-Tamfum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Ntoumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Zumla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22de%20Oliveira%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20J.%22%2C%22lastName%22%3A%22Mills%22%7D%5D%2C%22abstractNote%22%3A%22Recurrent%20disease%20outbreaks%20caused%20by%20a%20range%20of%20emerging%20and%20resurging%20pathogens%20over%20the%20past%20decade%20reveal%20major%20gaps%20in%20public%20health%20preparedness%2C%20detection%2C%20and%20response%20systems%20in%20Africa.%20Underlying%20causes%20of%20recurrent%20disease%20outbreaks%20include%20inadequacies%20in%20the%20detection%20of%20new%20infectious%20disease%20outbreaks%20in%20the%20community%2C%20in%20rapid%20pathogen%20identification%2C%20and%20in%20proactive%20surveillance%20systems.%20In%20sub-Saharan%20Africa%2C%20where%2070%25%20of%20zoonotic%20outbreaks%20occur%2C%20there%20remains%20the%20perennial%20risk%20of%20outbreaks%20of%20new%20or%20re-emerging%20pathogens%20for%20which%20no%20vaccines%20or%20treatments%20are%20available.%20As%20the%20Ebola%20virus%20disease%2C%20COVID-19%2C%20and%20mpox%20%28formerly%20known%20as%20monkeypox%29%20outbreaks%20highlight%2C%20a%20major%20paradigm%20shift%20is%20required%20to%20establish%20an%20effective%20infrastructure%20and%20common%20frameworks%20for%20preparedness%20and%20to%20prompt%20national%20and%20regional%20public%20health%20responses%20to%20mitigate%20the%20effects%20of%20future%20pandemics%20in%20Africa.%22%2C%22date%22%3A%22May%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS1473-3099%2822%2900723-X%22%2C%22ISSN%22%3A%221474-4457%20%28Electronic%29%201473-3099%20%28Print%29%201473-3099%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A14%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22DBNA47PF%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Murenzi%20et%20al.%22%2C%22parsedDate%22%3A%222023-05%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMurenzi%2C%20G.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKim%2C%20H.%20Y.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EShi%2C%20Q.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMuhoza%2C%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMunyaneza%2C%20A.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20Association%20Between%20Time%20to%20Antiretroviral%20Therapy%20and%20Loss%20to%20Care%20Among%20Newly%20Diagnosed%20Rwandan%20People%20Living%20with%20Human%20Immunodeficiency%20Virus.%20%3Ci%3EAIDS%20Res%20Hum%20Retroviruses%3C%5C%2Fi%3E%2C%20%3Ci%3E39%3C%5C%2Fi%3E%20%285%29%2C%20S.%20253%26%23x2013%3B261.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1089%5C%2FAID.2022.0023%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1089%5C%2FAID.2022.0023%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20Between%20Time%20to%20Antiretroviral%20Therapy%20and%20Loss%20to%20Care%20Among%20Newly%20Diagnosed%20Rwandan%20People%20Living%20with%20Human%20Immunodeficiency%20Virus%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20Y.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Q.%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Muhoza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Munyaneza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Kubwimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Remera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Nsanzimana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Ross%22%7D%5D%2C%22abstractNote%22%3A%22Despite%20improved%20clinical%20outcomes%20of%20initiating%20antiretroviral%20therapy%20%28ART%29%20soon%20after%20diagnosis%2C%20conflicting%20evidence%20exists%20regarding%20the%20impact%20of%20same-day%20ART%20initiation%20on%20subsequent%20clinical%20outcomes.%20We%20aimed%20to%20characterize%20the%20associations%20of%20time%20to%20ART%20initiation%20with%20loss%20to%20care%20and%20viral%20suppression%20in%20a%20cohort%20of%20newly%20diagnosed%20people%20living%20with%20HIV%20%28PLHIV%29%20entering%20care%20after%20Rwanda%20implemented%20a%20national%20%5C%22Treat%20All%5C%22%20policy.%20We%20conducted%20a%20secondary%20analysis%20of%20routinely%20collected%20data%20of%20adult%20PLHIV%20enrolling%20in%20HIV%20care%20at%2010%20health%20facilities%20in%20Kigali%2C%20Rwanda.%20Time%20from%20enrollment%20to%20ART%20initiation%20was%20categorized%20as%20same%20day%2C%201-7%20days%2C%20or%20%3E7%20days.%20We%20examined%20associations%20between%20time%20to%20ART%20and%20loss%20to%20care%20%28%3E120%20days%20since%20last%20health%20facility%20visit%29%20using%20Cox%20proportional%20hazards%20models%2C%20and%20between%20time%20to%20ART%20and%20viral%20suppression%20using%20logistic%20regression.%20Of%202%2C524%20patients%20included%20in%20this%20analysis%2C%201%2C452%20%2857.5%25%29%20were%20women%20and%20the%20median%20age%20was%2032%20%28interquartile%20range%3A%2026-39%29.%20Loss%20to%20care%20was%20more%20frequent%20among%20patients%20who%20initiated%20ART%20on%20the%20same%20day%20%2815.9%25%29%2C%20compared%20with%20those%20initiating%20ART%201-7%20days%20%2812.3%25%29%20or%20%3E7%20days%20%2810.1%25%29%2C%20p%20%3C%20.001.%20In%20multivariable%20analyses%2C%20same-day%20ART%20initiation%20was%20associated%20with%20a%20greater%20hazard%20of%20loss%20to%20care%20compared%20with%20initiating%20%3E7%20days%20after%20enrollment%20%28adjusted%20hazard%20ratio%201.39%2C%2095%25%20confidence%20interval%3A%201.04-1.85%29.%20A%20total%20of%201%2C698%20%2867.3%25%29%20had%20available%20data%20on%20viral%20load%20measured%20within%20455%20days%20after%20enrollment.%20Of%20these%2C%201%2C476%20%2887%25%29%20were%20virally%20suppressed.%20A%20higher%20proportion%20of%20patients%20initiating%20ART%20on%20the%20same%20day%20were%20virally%20suppressed%20%2889%25%29%20compared%20with%20those%20initiating%201-7%20days%20%2884%25%29%20or%20%3E7%20days%20%2888%25%29%20after%20enrollment.%20This%20association%20was%20not%20statistically%20significant.%20Our%20findings%20suggest%20that%20ensuring%20adequate%2C%20early%20support%20for%20PLHIV%20initiating%20ART%20rapidly%20may%20be%20important%20to%20improve%20retention%20in%20care%20for%20newly%20diagnosed%20PLHIV%20in%20the%20era%20of%20Treat%20All.%22%2C%22date%22%3A%22May%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1089%5C%2FAID.2022.0023%22%2C%22ISSN%22%3A%221931-8405%20%28Electronic%29%200889-2229%20%28Print%29%200889-2229%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A16%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22SF5ZU36U%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vreeman%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-13%22%2C%22numChildren%22%3A14%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EVreeman%2C%20R.%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EYiannoutsos%2C%20C.%20T.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EYusoff%2C%20N.%20K.%20N.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EWester%2C%20C.%20W.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEdmonds%2C%20A.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20Global%20HIV%20prevention%2C%20care%20and%20treatment%20services%20for%20children%3A%20a%20cross-sectional%20survey%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20%3Ci%3EBMJ%20Open%3C%5C%2Fi%3E%2C%20%3Ci%3E13%3C%5C%2Fi%3E%20%283%29%2C%20S.%20e069399.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2022-069399%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2022-069399%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Global%20HIV%20prevention%2C%20care%20and%20treatment%20services%20for%20children%3A%20a%20cross-sectional%20survey%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20C.%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20K.%20N.%22%2C%22lastName%22%3A%22Yusoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20W.%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Ofner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20A.%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Lumbiganon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20C.%22%2C%22lastName%22%3A%22de%20Menezes%20Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bolton-Moore%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20E.%22%2C%22lastName%22%3A%22Takassi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Scanlon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Martin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22IeDea%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVES%3A%20To%20assess%20access%20children%20with%20HIV%20have%20to%20comprehensive%20HIV%20care%20services%2C%20to%20longitudinally%20evaluate%20the%20implementation%20and%20scale-up%20of%20services%2C%20and%20to%20use%20site%20services%20and%20clinical%20cohort%20data%20to%20explore%20whether%20access%20to%20these%20services%20influences%20retention%20in%20care.%20METHODS%3A%20A%20cross-sectional%20standardised%20survey%20was%20completed%20in%202014-2015%20by%20sites%20providing%20paediatric%20HIV%20care%20across%20regions%20of%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20We%20developed%20a%20comprehensiveness%20score%20based%20on%20the%20WHO%27s%20nine%20categories%20of%20essential%20services%20to%20categorise%20sites%20as%20%27low%27%20%280-5%29%2C%20%27medium%27%2C%20%286-7%29%20or%20%27high%27%20%288-9%29.%20When%20available%2C%20comprehensiveness%20scores%20were%20compared%20with%20scores%20from%20a%202009%20survey.%20We%20used%20patient-level%20data%20with%20site%20services%20to%20investigate%20the%20relationship%20between%20the%20comprehensiveness%20of%20services%20and%20retention.%20RESULTS%3A%20Survey%20data%20from%20174%20IeDEA%20sites%20in%2032%20countries%20were%20analysed.%20Of%20the%20WHO%20essential%20services%2C%20sites%20were%20most%20likely%20to%20offer%20antiretroviral%20therapy%20%28ART%29%20provision%20and%20counselling%20%28n%3D173%3B%2099%25%29%2C%20co-trimoxazole%20prophylaxis%20%28168%3B%2097%25%29%2C%20prevention%20of%20perinatal%20transmission%20services%20%28167%3B%2096%25%29%2C%20outreach%20for%20patient%20engagement%20and%20follow-up%20%28166%3B%2095%25%29%2C%20CD4%20cell%20count%20testing%20%28126%3B%2088%25%29%2C%20tuberculosis%20screening%20%28151%3B%2087%25%29%20and%20select%20immunisation%20services%20%28126%3B%2072%25%29.%20Sites%20were%20less%20likely%20to%20offer%20nutrition%5C%2Ffood%20support%20%2897%3B%2056%25%29%2C%20viral%20load%20testing%20%2899%3B%2069%25%29%20and%20HIV%20counselling%20and%20testing%20%2869%3B%2040%25%29.%2010%25%20of%20sites%20rated%20%27low%27%2C%2059%25%20%27medium%27%20and%2031%25%20%27high%27%20in%20the%20comprehensiveness%20score.%20The%20mean%20comprehensiveness%20of%20services%20score%20increased%20significantly%20from%205.6%20in%202009%20to%207.3%20in%202014%20%28p%3C0.001%3B%20n%3D30%29.%20Patient-level%20analysis%20of%20lost%20to%20follow-up%20after%20ART%20initiation%20estimated%20the%20hazard%20was%20highest%20in%20sites%20rated%20%27low%27%20and%20lowest%20in%20sites%20rated%20%27high%27.%20CONCLUSION%3A%20This%20global%20assessment%20suggests%20the%20potential%20care%20impact%20of%20scaling-up%20and%20sustaining%20comprehensive%20paediatric%20HIV%20services.%20Meeting%20recommendations%20for%20comprehensive%20HIV%20services%20should%20remain%20a%20global%20priority.%22%2C%22date%22%3A%22Mar%2013%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2022-069399%22%2C%22ISSN%22%3A%222044-6055%20%28Electronic%29%202044-6055%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A19%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22UCFEFJNP%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222023-03%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EParcesepe%2C%20A.%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFiliatreau%2C%20L.%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EGomez%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEbasone%2C%20P.%20V.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EDzudie%2C%20A.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20HIV-Related%20Stigma%2C%20Social%20Support%2C%20and%20Symptoms%20of%20Mental%20Health%20Disorders%20Among%20People%20with%20HIV%20Initiating%20HIV%20Care%20in%20Cameroon.%20%3Ci%3EAIDS%20Patient%20Care%20STDS%3C%5C%2Fi%3E%2C%20%3Ci%3E37%3C%5C%2Fi%3E%20%283%29%2C%20S.%20146%26%23x2013%3B154.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1089%5C%2Fapc.2022.0187%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1089%5C%2Fapc.2022.0187%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV-Related%20Stigma%2C%20Social%20Support%2C%20and%20Symptoms%20of%20Mental%20Health%20Disorders%20Among%20People%20with%20HIV%20Initiating%20HIV%20Care%20in%20Cameroon%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20M.%22%2C%22lastName%22%3A%22Filiatreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20V.%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Dzudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20W.%22%2C%22lastName%22%3A%22Pence%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Wainberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Pefura-Yone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nsame%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22HIV-related%20stigma%20has%20been%20associated%20with%20poor%20mental%20health%20among%20people%20with%20HIV%20%28PWH%29.%20Social%20support%20is%20a%20potentially%20modifiable%20factor%20that%20may%20buffer%20negative%20mental%20health%20sequelae%20of%20HIV-related%20stigma.%20Little%20is%20known%20about%20the%20extent%20to%20which%20the%20modifying%20effect%20of%20social%20support%20differs%20across%20mental%20health%20disorders.%20Interviews%20were%20conducted%20with%20426%20PWH%20in%20Cameroon.%20Log%20binomial%20regression%20analyses%20were%20used%20to%20estimate%20the%20association%20between%20high%20anticipated%20HIV-related%20stigma%20and%20low%20social%20support%20from%20family%20or%20friends%20and%20symptoms%20of%20depression%2C%20anxiety%2C%20post-traumatic%20stress%20disorder%20%28PTSD%29%2C%20and%20harmful%20alcohol%20use%2C%20separately.%20Anticipated%20HIV-related%20stigma%20was%20commonly%20endorsed%20with%20approximately%2080%25%20endorsing%20at%20least%201%20of%2012%20stigma-related%20concerns.%20In%20multivariable%20analyses%2C%20high%20anticipated%20HIV-related%20stigma%20was%20associated%20with%20greater%20prevalence%20of%20symptoms%20of%20depression%20adjusted%20prevalence%20ratio%20%28aPR%29%201.6%20%5B95%25%20confidence%20interval%20%28CI%29%201.1-2.2%5D%20and%20anxiety%20%5BaPR%202.0%20%2895%25%20CI%201.4-2.9%29%5D.%20Low%20social%20support%20was%20associated%20with%20greater%20prevalence%20of%20symptoms%20of%20depression%20%5BaPR%201.5%20%2895%25%20CI%201.1-2.2%29%5D%2C%20anxiety%20%5BaPR%201.7%20%2895%25%20CI%201.2-2.5%29%5D%2C%20and%20PTSD%20%5BaPR%201.6%20%2895%25%20CI%201.0-2.4%29%5D.%20However%2C%20social%20support%20did%20not%20meaningfully%20modify%20the%20relationship%20between%20HIV-related%20stigma%20and%20symptoms%20of%20any%20mental%20health%20disorders%20explored.%20Anticipated%20HIV-related%20stigma%20was%20commonly%20reported%20among%20this%20group%20of%20PWH%20initiating%20HIV%20care%20in%20Cameroon.%20Social%20concerns%20related%20to%20gossip%20or%20losing%20friends%20were%20of%20the%20greatest%20concern.%20Interventions%20focused%20on%20reducing%20stigma%20and%20strengthening%20support%20systems%20may%20be%20particularly%20beneficial%20and%20have%20the%20potential%20to%20improve%20the%20mental%20health%20of%20PWH%20in%20Cameroon.%22%2C%22date%22%3A%22Mar%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1089%5C%2Fapc.2022.0187%22%2C%22ISSN%22%3A%221557-7449%20%28Electronic%29%201087-2914%20%28Print%29%201087-2914%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A47%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22DQZY2PUS%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ross%20et%20al.%22%2C%22parsedDate%22%3A%222023-01-06%22%2C%22numChildren%22%3A16%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERoss%2C%20J.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrazier%2C%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFatti%2C%20G.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJaquet%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ETanon%2C%20A.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20Same-Day%20Antiretroviral%20Therapy%20Initiation%20as%20a%20Predictor%20of%20Loss%20to%20Follow-up%20and%20Viral%20Suppression%20Among%20People%20With%20Human%20Immunodeficiency%20Virus%20in%20Sub-Saharan%20Africa.%20%3Ci%3EClin%20Infect%20Dis%3C%5C%2Fi%3E%2C%20%3Ci%3E76%3C%5C%2Fi%3E%20%281%29%2C%20S.%2039%26%23x2013%3B47.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciac759%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fcid%5C%2Fciac759%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Same-Day%20Antiretroviral%20Therapy%20Initiation%20as%20a%20Predictor%20of%20Loss%20to%20Follow-up%20and%20Viral%20Suppression%20Among%20People%20With%20Human%20Immunodeficiency%20Virus%20in%20Sub-Saharan%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Ross%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Fatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Tanon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20M.%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Treat-All%20guidelines%20recommend%20initiation%20of%20antiretroviral%20therapy%20%28ART%29%20for%20all%20people%20with%20HIV%20%28PWH%29%20on%20the%20day%20of%20diagnosis%20when%20possible%2C%20yet%20uncertainty%20exists%20about%20the%20impact%20of%20same-day%20ART%20initiation%20on%20subsequent%20care%20engagement.%20We%20examined%20the%20association%20of%20same-day%20ART%20initiation%20with%20loss%20to%20follow-up%20and%20viral%20suppression%20among%20patients%20in%2011%20sub-Saharan%20African%20countries.%20METHODS%3A%20We%20included%20ART-naive%20adult%20PWH%20from%20sites%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%20who%20enrolled%20in%20care%20after%20Treat-All%20implementation%20and%20prior%20to%20January%202019.%20We%20used%20multivariable%20Cox%20regression%20to%20estimate%20the%20association%20between%20same-day%20ART%20initiation%20and%20loss%20to%20follow-up%20and%20Poisson%20regression%20to%20estimate%20the%20association%20between%20same-day%20ART%20initiation%20and%206-month%20viral%20suppression.%20RESULTS%3A%20Among%2029%20017%20patients%20from%2063%20sites%2C%2018%20584%20%2864.0%25%29%20initiated%20ART%20on%20the%20day%20of%20enrollment.%20Same-day%20ART%20initiation%20was%20less%20likely%20among%20those%20with%20advanced%20HIV%20disease%20versus%20early-stage%20disease.%20Loss%20to%20follow-up%20was%20significantly%20lower%20among%20those%20initiating%20ART%20%3E%5C%2F%3D1%20day%20of%20enrollment%2C%20compared%20with%20same-day%20ART%20initiators%20%2820.6%25%20vs%2027.7%25%3B%20adjusted%20hazard%20ratio%3A%20.66%3B%2095%25%20CI%20.57-.76%29.%20No%20difference%20in%20viral%20suppression%20was%20observed%20by%20time%20to%20ART%20initiation%20%28adjusted%20rate%20ratio%3A%201.00%3B%2095%25%20CI%3A%20.98-1.02%29.%20CONCLUSIONS%3A%20Patients%20initiating%20ART%20on%20the%20day%20of%20enrollment%20were%20more%20frequently%20lost%20to%20follow-up%20than%20those%20initiating%20later%20but%20were%20equally%20likely%20to%20be%20virally%20suppressed.%20Our%20findings%20support%20recent%20World%20Health%20Organization%20recommendations%20for%20providing%20tailored%20counseling%20and%20support%20to%20patients%20who%20accept%20an%20offer%20of%20same-day%20ART.%22%2C%22date%22%3A%22Jan%206%202023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1093%5C%2Fcid%5C%2Fciac759%22%2C%22ISSN%22%3A%221537-6591%20%28Electronic%29%201058-4838%20%28Print%29%201058-4838%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A27%3A31Z%22%7D%7D%2C%7B%22key%22%3A%226YLLHW7Q%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222023%22%2C%22numChildren%22%3A16%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrazier%2C%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMaruri%2C%20F.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EWester%2C%20C.%20W.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMusick%2C%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFreeman%2C%20A.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282023%29.%20Design%20and%20implementation%20of%20a%20global%20site%20assessment%20survey%20among%20HIV%20clinics%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium.%20%3Ci%3EPLoS%20One%3C%5C%2Fi%3E%2C%20%3Ci%3E18%3C%5C%2Fi%3E%20%283%29%2C%20S.%20e0268167.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0268167%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0268167%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Design%20and%20implementation%20of%20a%20global%20site%20assessment%20survey%20among%20HIV%20clinics%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20W.%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Hossmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Christ%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Kimmel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20E.%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20E.%22%2C%22lastName%22%3A%22Golub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aids%20consortium%22%2C%22lastName%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Timely%20descriptions%20of%20HIV%20service%20characteristics%20and%20their%20evolution%20over%20time%20across%20diverse%20settings%20are%20important%20for%20monitoring%20the%20scale-up%20of%20evidence-based%20program%20strategies%2C%20understanding%20the%20implementation%20landscape%2C%20and%20examining%20service%20delivery%20factors%20that%20influence%20HIV%20care%20outcomes.%20METHODS%3A%20The%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%20undertakes%20periodic%20cross-sectional%20surveys%20on%20service%20availability%20and%20care%20at%20participating%20HIV%20treatment%20sites%20to%20characterize%20trends%20and%20inform%20the%20scientific%20agenda%20for%20HIV%20care%20and%20implementation%20science%20communities.%20IeDEA%27s%202020%20general%20site%20assessment%20survey%20was%20developed%20through%20a%20consultative%2C%2018-month%20process%20that%20engaged%20diverse%20researchers%20in%20identifying%20content%20from%20previous%20surveys%20that%20should%20be%20retained%20for%20longitudinal%20analyses%20and%20in%20developing%20expanded%20and%20new%20content%20to%20address%20gaps%20in%20the%20literature.%20An%20iterative%20review%20process%20was%20undertaken%20to%20standardize%20the%20format%20of%20new%20survey%20questions%20and%20align%20them%20with%20best%20practices%20in%20survey%20design%20and%20measurement%20and%20lessons%20learned%20through%20prior%20IeDEA%20site%20assessment%20surveys.%20RESULTS%3A%20The%20survey%20questionnaire%20developed%20through%20this%20process%20included%20eight%20content%20domains%20covered%20in%20prior%20surveys%20%28patient%20population%2C%20staffing%20and%20community%20linkages%2C%20HIV%20testing%20and%20diagnosis%2C%20new%20patient%20care%2C%20treatment%20monitoring%20and%20retention%2C%20routine%20HIV%20care%20and%20screening%2C%20pharmacy%2C%20record-keeping%20and%20patient%20tracing%29%2C%20along%20with%20expanded%20content%20related%20to%20antiretroviral%20therapy%20%28differentiated%20service%20delivery%20and%20roll-out%20of%20dolutegravir-based%20regimens%29%3B%20mental%20health%20and%20substance%20use%20disorders%3B%20care%20for%20pregnant%5C%2Fpostpartum%20women%20and%20HIV-exposed%20infants%3B%20tuberculosis%20preventive%20therapy%3B%20and%20pediatric%5C%2Fadolescent%20tuberculosis%20care%3B%20and%20new%20content%20related%20to%20Kaposi%27s%20sarcoma%20diagnostics%2C%20the%20impact%20of%20COVID-19%20on%20service%20delivery%2C%20and%20structural%20barriers%20to%20HIV%20care.%20The%20survey%20was%20distributed%20to%20238%20HIV%20treatment%20sites%20in%20late%202020%2C%20with%20a%2095%25%20response%20rate.%20CONCLUSION%3A%20IeDEA%27s%20approach%20for%20site%20survey%20development%20has%20broad%20relevance%20for%20HIV%20research%20networks%20and%20other%20priority%20health%20conditions.%22%2C%22date%22%3A%222023%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0268167%22%2C%22ISSN%22%3A%221932-6203%20%28Electronic%29%201932-6203%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A18%3A14Z%22%7D%7D%5D%7D
Zotova, Natalia; Munyaneza, Athanase; Murenzi, Gad; Kubwimana, Gallican; Adedimeji, Adebola et al. (2023). Low birth weight among infants and pregnancy outcomes among women living with HIV and HIV-negative women in Rwanda.
Research Square, S. rs.3.rs-3467879.
http://doi.org/10.21203/rs.3.rs-3467879/v1.
Ingabire, Charles; Watnick, Dana; Gasana, Josephine; Umwiza, Francine; Munyaneza, Athanase et al. (2023). Experiences of stigma and HIV care engagement in the context of Treat All in Rwanda: a qualitative study.
BMC Public Health,
23 (1), S. 1817.
http://doi.org/10.1186/s12889-023-16752-y.
Nachega, Jean B.; Musoke, Philippa; Kilmarx, Peter H.; Gandhi, Monica; Grinsztejn, Beatriz et al. (2023). Global HIV control: is the glass half empty or half full?
The Lancet. HIV,
10 (9), S. e617–e622.
http://doi.org/10.1016/S2352-3018(23)00150-9.
Parcesepe, Angela M.; Stockton, Melissa; Remch, Molly; Wester, C. William; Bernard, Charlotte et al. (2023). Availability of screening and treatment for common mental disorders in HIV clinic settings: data from the global International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium, 2016-2017 and 2020.
Journal of the International AIDS Society,
26 (8), S. e26147.
http://doi.org/10.1002/jia2.26147.
Chiarappa, Joseph A.;
Hoover, Donald R. &
Pedley, Alison (2023). Economizing comparative Poisson clinical trials of multiple experimental treatments by testing against the same control.
Statistical Methods in Medical Research,
32 (8), S. 1604–1615.
http://doi.org/10.1177/09622802231181235.
Parcesepe, A. M.; Filiatreau, L. M.; Gomez, A.; Ebasone, P. V.; Dzudie, A. et al. (2023). Coping Strategies and Symptoms of Mental Health Disorders Among People with HIV Initiating HIV Care in Cameroon.
AIDS Behav,
27 (7), S. 2360–2369.
http://doi.org/10.1007/s10461-022-03963-4.
Nachega, J. B.; Nsanzimana, S.; Rawat, A.; Wilson, L. A.; Rosenthal, P. J. et al. (2023). Advancing detection and response capacities for emerging and re-emerging pathogens in Africa.
Lancet Infect Dis,
23 (5), S. e185–e189.
http://doi.org/10.1016/S1473-3099(22)00723-X.
Murenzi, G.; Kim, H. Y.; Shi, Q.; Muhoza, B.; Munyaneza, A. et al. (2023). Association Between Time to Antiretroviral Therapy and Loss to Care Among Newly Diagnosed Rwandan People Living with Human Immunodeficiency Virus.
AIDS Res Hum Retroviruses,
39 (5), S. 253–261.
http://doi.org/10.1089/AID.2022.0023.
Vreeman, R. C.; Yiannoutsos, C. T.; Yusoff, N. K. N.; Wester, C. W.; Edmonds, A. et al. (2023). Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium.
BMJ Open,
13 (3), S. e069399.
http://doi.org/10.1136/bmjopen-2022-069399.
Parcesepe, A. M.; Filiatreau, L. M.; Gomez, A.; Ebasone, P. V.; Dzudie, A. et al. (2023). HIV-Related Stigma, Social Support, and Symptoms of Mental Health Disorders Among People with HIV Initiating HIV Care in Cameroon.
AIDS Patient Care STDS,
37 (3), S. 146–154.
http://doi.org/10.1089/apc.2022.0187.
Ross, J.; Brazier, E.; Fatti, G.; Jaquet, A.; Tanon, A. et al. (2023). Same-Day Antiretroviral Therapy Initiation as a Predictor of Loss to Follow-up and Viral Suppression Among People With Human Immunodeficiency Virus in Sub-Saharan Africa.
Clin Infect Dis,
76 (1), S. 39–47.
http://doi.org/10.1093/cid/ciac759.
Brazier, E.; Maruri, F.; Wester, C. W.; Musick, B.; Freeman, A. et al. (2023). Design and implementation of a global site assessment survey among HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) research consortium.
PLoS One,
18 (3), S. e0268167.
http://doi.org/10.1371/journal.pone.0268167.
2775998
ZVWK2Q45
2022
items
1
0
date
desc
year
257
https://www.iedea.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-462cd16c54a1d75a68c0469ff3504671%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%224QMJKWAF%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Brazier%20et%20al.%22%2C%22parsedDate%22%3A%222022-12%22%2C%22numChildren%22%3A16%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrazier%2C%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAjeh%2C%20R.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMaruri%2C%20F.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMusick%2C%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFreeman%2C%20A.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Service%20delivery%20challenges%20in%20HIV%20care%20during%20the%20first%20year%20of%20the%20COVID-19%20pandemic%3A%20results%20from%20a%20site%20assessment%20survey%20across%20the%20global%20IeDEA%20consortium.%20%3Ci%3EJ%20Int%20AIDS%20Soc%3C%5C%2Fi%3E%2C%20%3Ci%3E25%3C%5C%2Fi%3E%20%2812%29%2C%20S.%20e26036.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26036%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.26036%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Service%20delivery%20challenges%20in%20HIV%20care%20during%20the%20first%20year%20of%20the%20COVID-19%20pandemic%3A%20results%20from%20a%20site%20assessment%20survey%20across%20the%20global%20IeDEA%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Maruri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Freeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20W.%22%2C%22lastName%22%3A%22Wester%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20P.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Shamu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Crabtree%20Ramirez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22d%27Almeida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Kumarasamy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Grinsztejn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Tanser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Byakwaga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aids%22%2C%22lastName%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Interruptions%20in%20treatment%20pose%20risks%20for%20people%20with%20HIV%20%28PWH%29%20and%20threaten%20progress%20in%20ending%20the%20HIV%20epidemic%3B%20however%2C%20the%20COVID-19%20pandemic%27s%20impact%20on%20HIV%20service%20delivery%20across%20diverse%20settings%20is%20not%20broadly%20documented.%20METHODS%3A%20From%20September%202020%20to%20March%202021%2C%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20research%20consortium%20surveyed%20238%20HIV%20care%20sites%20across%20seven%20geographic%20regions%20to%20document%20constraints%20in%20HIV%20service%20delivery%20during%20the%20first%20year%20of%20the%20pandemic%20and%20strategies%20for%20ensuring%20care%20continuity%20for%20PWH.%20Descriptive%20statistics%20were%20stratified%20by%20national%20HIV%20prevalence%20%28%3C1%25%2C%201-4.9%25%20and%20%3E%5C%2F%3D5%25%29%20and%20country%20income%20levels.%20RESULTS%3A%20Questions%20about%20pandemic-related%20consequences%20for%20HIV%20care%20were%20completed%20by%20225%20%2895%25%29%20sites%20in%2042%20countries%20with%20low%20%28n%20%3D%2082%29%2C%20medium%20%28n%20%3D%2086%29%20and%20high%20%28n%20%3D%2057%29%20HIV%20prevalence%2C%20including%20low-%20%28n%20%3D%2057%29%2C%20lower-middle%20%28n%20%3D%2079%29%2C%20upper-middle%20%28n%20%3D%2039%29%20and%20high-%20%28n%20%3D%2050%29%20income%20countries.%20Most%20sites%20reported%20being%20subject%20to%20pandemic-related%20restrictions%20on%20travel%2C%20service%20provision%20or%20other%20operations%20%2875%25%29%2C%20and%20experiencing%20negative%20impacts%20%2876%25%29%20on%20clinic%20operations%2C%20including%20decreased%20hours%5C%2Fdays%2C%20reduced%20provider%20availability%2C%20clinic%20reconfiguration%20for%20COVID-19%20services%2C%20record-keeping%20interruptions%20and%20suspension%20of%20partner%20support.%20Almost%20all%20sites%20in%20low-prevalence%20and%20high-income%20countries%20reported%20increased%20use%20of%20telemedicine%20%2885%25%20and%20100%25%2C%20respectively%29%2C%20compared%20with%20less%20than%20half%20of%20sites%20in%20high-prevalence%20and%20lower-income%20settings.%20Few%20sites%20in%20high-prevalence%20settings%20%282%25%29%20reported%20suspending%20antiretroviral%20therapy%20%28ART%29%20clinic%20services%2C%20and%20many%20reported%20adopting%20mitigation%20strategies%20to%20support%20adherence%2C%20including%20multi-month%20dispensing%20of%20ART%20%2895%25%29%20and%20designating%20community%20ART%20pick-up%20points%20%2844%25%29.%20While%20few%20sites%20%285%25%29%20reported%20stockouts%20of%20first-line%20ART%20regimens%2C%2010-11%25%20reported%20stockouts%20of%20second-%20and%20third-line%20regimens%2C%20respectively%2C%20primarily%20in%20high-prevalence%20and%20lower-income%20settings.%20Interruptions%20in%20HIV%20viral%20load%20%28VL%29%20testing%20included%20suspension%20of%20testing%20%2822%25%29%2C%20longer%20turnaround%20times%20%2841%25%29%20and%20supply%5C%2Freagent%20stockouts%20%2822%25%29%2C%20but%20did%20not%20differ%20across%20settings.%20CONCLUSIONS%3A%20While%20many%20sites%20in%20high%20HIV%20prevalence%20settings%20and%20lower-income%20countries%20reported%20introducing%20or%20expanding%20measures%20to%20support%20treatment%20adherence%20and%20continuity%20of%20care%2C%20the%20COVID-19%20pandemic%20resulted%20in%20disruptions%20to%20VL%20testing%20and%20ART%20supply%20chains%20that%20may%20negatively%20affect%20the%20quality%20of%20HIV%20care%20in%20these%20settings.%22%2C%22date%22%3A%22Dec%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.26036%22%2C%22ISSN%22%3A%221758-2652%20%28Electronic%29%201758-2652%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A27%3A57Z%22%7D%7D%2C%7B%22key%22%3A%22YNT7B8LY%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wada%20et%20al.%22%2C%22parsedDate%22%3A%222022-09%22%2C%22numChildren%22%3A12%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EWada%2C%20P.%20Y.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKim%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJayathilake%2C%20K.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EDuda%2C%20S.%20N.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAbo%2C%20Y.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Site-Level%20Comprehensiveness%20of%20Care%20Is%20Associated%20with%20Individual%20Clinical%20Retention%20Among%20Adults%20Living%20with%20HIV%20in%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%2C%20a%20Global%20HIV%20Cohort%20Collaboration%2C%202000-2016.%20%3Ci%3EAIDS%20Patient%20Care%20STDS%3C%5C%2Fi%3E%2C%20%3Ci%3E36%3C%5C%2Fi%3E%20%289%29%2C%20S.%20343%26%23x2013%3B355.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1089%5C%2Fapc.2022.0042%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1089%5C%2Fapc.2022.0042%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Site-Level%20Comprehensiveness%20of%20Care%20Is%20Associated%20with%20Individual%20Clinical%20Retention%20Among%20Adults%20Living%20with%20HIV%20in%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%2C%20a%20Global%20HIV%20Cohort%20Collaboration%2C%202000-2016%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20Y.%22%2C%22lastName%22%3A%22Wada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%22%2C%22lastName%22%3A%22Abo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%20J.%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20T.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Cesar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20C.%22%2C%22lastName%22%3A%22McGowan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20F.%22%2C%22lastName%22%3A%22Rebeiro%22%7D%5D%2C%22abstractNote%22%3A%22Retention%20in%20care%20%28RIC%29%20reduces%20HIV%20transmission%20and%20associated%20morbidity%20and%20mortality.%20We%20examined%20whether%20delivery%20of%20comprehensive%20services%20influenced%20individual%20RIC%20within%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20network.%20We%20collected%20site%20data%20through%20IeDEA%20assessments%201.0%20%282000-2009%29%20and%202.0%20%282010-2016%29.%20Each%20site%20received%20a%20comprehensiveness%20score%20for%20service%20availability%20%281%20%3D%20present%2C%200%20%3D%20absent%29%2C%20with%20tallies%20ranging%20from%200%20to%207.%20We%20obtained%20individual-level%20cohort%20data%20for%20adults%20with%20at%20least%20one%20visit%20from%202000%20to%202016%20at%20sites%20responding%20to%20either%20assessment.%20Person-time%20was%20recorded%20annually%2C%20with%20RIC%20defined%20as%20completing%20two%20visits%20at%20least%2090%20days%20apart%20in%20each%20calendar%20year.%20Multivariable%20modified%20Poisson%20regression%20clustered%20by%20site%20yielded%20risk%20ratios%20and%20predicted%20probabilities%20for%20individual%20RIC%20by%20comprehensiveness.%20Among%20347%2C060%20individuals%20in%20care%20at%20122%20sites%20with%201%2C619%2C558%20person-years%20of%20follow-up%2C%2069.8%25%20of%20person-time%20was%20retained%20in%20care%2C%20varying%20by%20region%20from%2053.8%25%20%28Asia-Pacific%29%20to%2082.7%25%20%28East%20Africa%29%3B%20RIC%20improved%20by%20about%202%25%20per%20year%20from%202000%20to%202016%20%28p%20%3D%200.012%29.%20Every%20site%20provided%20CD4%28%2B%29%20count%20testing%2C%20and%20%3E90%25%20of%20individuals%20received%20care%20at%20sites%20that%20provided%20combination%20antiretroviral%20therapy%20adherence%20measures%2C%20prevention%20of%20mother-to-child%20transmission%2C%20tuberculosis%20screening%2C%20HIV-related%20prevention%2C%20and%20community%20tracing%20services.%20In%20adjusted%20models%2C%20individuals%20at%20sites%20with%20more%20comprehensive%20services%20had%20higher%20probabilities%20of%20RIC%20%280.71%2C%200.74%2C%20and%200.83%20for%20scores%205%2C%206%2C%20and%207%2C%20respectively%3B%20p%20%3D%200.019%29.%20Within%20IeDEA%2C%20greater%20site-level%20comprehensiveness%20of%20services%20was%20associated%20with%20improved%20individual%20RIC.%20Much%20work%20remains%20in%20exploring%20this%20relationship%2C%20which%20may%20inform%20HIV%20clinical%20practice%20and%20health%20systems%20planning.%22%2C%22date%22%3A%22Sep%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1089%5C%2Fapc.2022.0042%22%2C%22ISSN%22%3A%221557-7449%20%28Electronic%29%201087-2914%20%28Print%29%201087-2914%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A28%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22LKS2Q8F6%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Edmonds%20et%20al.%22%2C%22parsedDate%22%3A%222022-09%22%2C%22numChildren%22%3A12%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEdmonds%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrazier%2C%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMusick%2C%20B.%20S.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EYotebieng%2C%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EHumphrey%2C%20J.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Clinical%20and%20programmatic%20outcomes%20of%20HIV-exposed%20infants%20enrolled%20in%20care%20at%20geographically%20diverse%20clinics%2C%201997-2021%3A%20A%20cohort%20study.%20%3Ci%3EPLoS%20Med%3C%5C%2Fi%3E%2C%20%3Ci%3E19%3C%5C%2Fi%3E%20%289%29%2C%20S.%20e1004089.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pmed.1004089%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pmed.1004089%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20and%20programmatic%20outcomes%20of%20HIV-exposed%20infants%20enrolled%20in%20care%20at%20geographically%20diverse%20clinics%2C%201997-2021%3A%20A%20cohort%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20S.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20L.%22%2C%22lastName%22%3A%22Abuogi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Keiser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Msukwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20G.%22%2C%22lastName%22%3A%22Carlucci%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Maia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20A.%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Leroy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20A.%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22IeDea%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Marie-Louise%22%2C%22lastName%22%3A%22Newell%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Although%201.3%20million%20women%20with%20HIV%20give%20birth%20annually%2C%20care%20and%20outcomes%20for%20HIV-exposed%20infants%20remain%20incompletely%20understood.%20We%20analyzed%20programmatic%20and%20health%20indicators%20in%20a%20large%2C%20multidecade%20global%20dataset%20of%20linked%20mother-infant%20records%20from%20clinics%20and%20programs%20associated%20with%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20METHODS%20AND%20FINDINGS%3A%20HIV-exposed%20infants%20were%20eligible%20for%20this%20retrospective%20cohort%20analysis%20if%20enrolled%20at%20%3C18%20months%20at%20198%20clinics%20in%2010%20countries%20across%205%20IeDEA%20regions%3A%20East%20Africa%20%28EA%29%2C%20Central%20Africa%20%28CA%29%2C%20West%20Africa%20%28WA%29%2C%20Southern%20Africa%20%28SA%29%2C%20and%20the%20Caribbean%2C%20Central%2C%20and%20South%20America%20network%20%28CCASAnet%29.%20We%20estimated%20cumulative%20incidences%20of%20DNA%20PCR%20testing%2C%20loss%20to%20follow-up%20%28LTFU%29%2C%20HIV%20diagnosis%2C%20and%20death%20through%2024%20months%20of%20age%20using%20proportional%20subdistribution%20hazard%20models%20accounting%20for%20competing%20risks.%20Competing%20risks%20were%20transfer%2C%20care%20withdrawal%2C%20and%20confirmation%20of%20negative%20HIV%20status%2C%20along%20with%20LTFU%20and%20death%2C%20when%20not%20the%20outcome%20of%20interest.%20In%20CA%20and%20EA%2C%20we%20quantified%20associations%20between%20maternal%5C%2Finfant%20characteristics%20and%20each%20outcome.%20A%20total%20of%2082%2C067%20infants%20%2847%2C300%20EA%2C%2010%2C699%20CA%2C%206%2C503%20WA%2C%2015%2C770%20SA%2C%201%2C795%20CCASAnet%29%20born%20from%201997%20to%202021%20were%20included.%20Maternal%20antiretroviral%20therapy%20%28ART%29%20use%20during%20pregnancy%20ranged%20from%2065.6%25%20%28CCASAnet%29%20to%2089.5%25%20%28EA%29%2C%20with%20improvements%20in%20all%20regions%20over%20time.%20Twenty-four-month%20cumulative%20incidences%20varied%20widely%20across%20regions%2C%20ranging%20from%2012.3%25%20%2895%25%20confidence%20limit%20%5BCL%5D%2C%2011.2%25%2C13.5%25%29%20in%20WA%20to%2094.8%25%20%2895%25%20CL%2C%2094.6%25%2C95.1%25%29%20in%20EA%20for%20DNA%20PCR%20testing%3B%2056.2%25%20%2895%25%20CL%2C%2055.2%25%2C57.1%25%29%20in%20EA%20to%2098.5%25%20%2895%25%20CL%2C%2098.3%25%2C98.7%25%29%20in%20WA%20for%20LTFU%3B%201.9%25%20%2895%25%20CL%2C%201.6%25%2C2.3%25%29%20in%20WA%20to%2010.3%25%20%2895%25%20CL%2C%209.7%25%2C10.9%25%29%20in%20EA%20for%20HIV%20diagnosis%3B%20and%200.5%25%20%2895%25%20CL%2C%200.2%25%2C1.0%25%29%20in%20CCASAnet%20to%204.7%25%20%2895%25%20CL%2C%204.4%25%2C5.0%25%29%20in%20EA%20for%20death.%20Although%20infant%20retention%20did%20not%20improve%2C%20HIV%20diagnosis%20and%20death%20decreased%20over%20time%2C%20and%20in%20EA%2C%20the%20cumulative%20incidence%20of%20HIV%20diagnosis%20decreased%20substantially%2C%20declining%20to%202.9%25%20%2895%25%20CL%2C%201.5%25%2C5.4%25%29%20in%202020.%20Maternal%20ART%20was%20associated%20with%20decreased%20infant%20mortality%20%28subdistribution%20hazard%20ratio%20%5BsdHR%5D%2C%200.65%3B%2095%25%20CL%2C%200.47%2C0.91%20in%20EA%2C%20and%20sdHR%2C%200.51%3B%2095%25%20CL%2C%200.36%2C0.74%20in%20CA%29%20and%20HIV%20diagnosis%20%28sdHR%2C%200.40%3B%2095%25%20CL%2C%200.31%2C0.50%20in%20EA%2C%20and%20sdHR%2C%200.41%3B%2095%25%20CL%2C%200.31%2C0.54%20in%20CA%29.%20Study%20limitations%20include%20potential%20misclassification%20of%20outcomes%20in%20real-world%20service%20delivery%20data%20and%20possible%20nonrepresentativeness%20of%20IeDEA%20sites%20and%20the%20population%20of%20HIV-exposed%20infants%20they%20serve.%20CONCLUSIONS%3A%20While%20there%20was%20marked%20regional%20and%20temporal%20heterogeneity%20in%20clinical%20and%20programmatic%20outcomes%2C%20infant%20LTFU%20was%20high%20across%20all%20regions%20and%20time%20periods.%20Further%20efforts%20are%20needed%20to%20keep%20HIV-exposed%20infants%20in%20care%20to%20receive%20essential%20services%20to%20reduce%20HIV%20infection%20and%20mortality.%22%2C%22date%22%3A%22Sep%202022%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pmed.1004089%22%2C%22ISSN%22%3A%221549-1676%20%28Electronic%29%201549-1277%20%28Print%29%201549-1277%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A17%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22EQJ3YSKM%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Murenzi%20et%20al.%22%2C%22parsedDate%22%3A%222022-08-25%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMurenzi%2C%20G.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EShumbusho%2C%20F.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EHansen%2C%20N.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMunyaneza%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EGage%2C%20J.%20C.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Long-term%20human%20papillomavirus%20vaccination%20effectiveness%20and%20immunity%20in%20Rwandan%20women%20living%20with%20and%20without%20HIV%3A%20a%20study%20protocol.%20%3Ci%3EBMJ%20Open%3C%5C%2Fi%3E%2C%20%3Ci%3E12%3C%5C%2Fi%3E%20%288%29%2C%20S.%20e061650.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2022-061650%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjopen-2022-061650%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Long-term%20human%20papillomavirus%20vaccination%20effectiveness%20and%20immunity%20in%20Rwandan%20women%20living%20with%20and%20without%20HIV%3A%20a%20study%20protocol%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Shumbusho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Hansen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Munyaneza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20C.%22%2C%22lastName%22%3A%22Gage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Muhoza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Kanyabwisha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Pierz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Tuyisenge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20E.%22%2C%22lastName%22%3A%22Castle%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Prophylactic%20human%20papillomavirus%20%28HPV%29%20vaccines%20have%20been%20shown%20to%20be%20highly%20effective%20in%20protecting%20women%20against%20cervical%20infections%2C%20high-grade%20abnormalities%20and%20cancer%20caused%20by%20the%20targeted%20HPV%20types.%20However%2C%20the%20evidence%20for%20their%20effectiveness%20in%20women%20living%20with%20HIV%20%28WLWH%29%20is%20less%20clear.%20METHODS%3A%20WLWH%20and%20HIV-negative%20women%20who%20likely%20did%20%28birth%20cohorts%201996%20and%20later%29%20and%20WLWH%20and%20HIV%28-%29%20negative%20who%20likely%20did%20not%20%28birth%20cohorts%20before%201996%29%20receive%20HPV%20vaccination%20%28n%3D3028%3B%20757%20participants%20for%20each%20of%20the%20four%20groups%29.%20Between%20groups%2C%20we%20will%20compare%20cervicovaginal%2C%20anal%20and%20oral%20prevalent%20and%206-12%20month%20persistent%20HPV6%5C%2F11%5C%2F16%5C%2F18%20infections%20as%20measured%20using%20a%20modified%20AmpFire%20HPV%20genotyping%20assay%20that%20tests%20for%2015%20high-risk%20or%20intermediate-risk%20HPV%20genotypes%2C%20HPV6%20and%20HPV11.%20We%20will%20also%20compare%20the%20HPV%20immune%20response%20in%20HPV-vaccinated%20WLWH%20to%20HPV-vaccinated%20HIV-negative%20women%20using%20an%20anti-HPV16%20and%20anti-HPV18%20ELISA.%20Vaccination%20status%20will%20be%20confirmed%20through%20national%20vaccination%20records.%20ANALYSIS%3A%20We%20will%20calculate%20point%20prevalence%20and%20prevalence%20of%206-12%20month%20persisting%20infections%20by%20individual%20HPV-type%20specific%20infections%20and%20groups%20of%20infections%20for%20each%20anatomic%20site%20and%20for%20each%20group%20of%20women.%20Results%20will%20be%20stratified%20by%20age%20at%20vaccination%2C%20age%20at%20enrolment%20and%20the%20number%20of%20doses%20%283%20vs%202%29%20as%20well%20as%20other%20factors%20possibly%20associated%20with%20HPV%20prevalence.%20Differences%20in%20endpoints%20between%20groups%2C%20overall%20and%20between%20subgroups%2C%20will%20be%20tested%20for%20statistical%20significance%20%28p%3C0.05%29%20using%20Fisher%27s%20exact%20or%20Pearson%20chi%282%29%20test.%20Differences%20in%20geometric%20mean%20titres%20and%20seropositivity%20will%20be%20tested%20for%20statistical%20significance%20using%20the%20Mann-Whitney%20and%20Fisher%27s%20exact%20tests%2C%20respectively.%20ETHICS%20AND%20DISSEMINATION%3A%20The%20study%20was%20approved%20by%20the%20Albert%20Einstein%20College%20of%20Medicine%20Institutional%20Review%20Board%20and%20the%20Rwanda%20National%20Ethics%20Committee.%20Results%20will%20be%20disseminated%20through%20publication%20in%20peer-reviewed%20journals.%22%2C%22date%22%3A%22Aug%2025%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjopen-2022-061650%22%2C%22ISSN%22%3A%222044-6055%20%28Electronic%29%202044-6055%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A37%3A05Z%22%7D%7D%2C%7B%22key%22%3A%22RZ37868F%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Filiatreau%20et%20al.%22%2C%22parsedDate%22%3A%222022-07-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFiliatreau%2C%20L.%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEbasone%2C%20P.%20V.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EDzudie%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAjeh%2C%20R.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EPence%2C%20B.%20W.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Prevalence%20of%20stressful%20life%20events%20and%20associations%20with%20symptoms%20of%20depression%2C%20anxiety%2C%20and%20post-traumatic%20stress%20disorder%20among%20people%20entering%20care%20for%20HIV%20in%20Cameroon.%20%3Ci%3EJ%20Affect%20Disord%3C%5C%2Fi%3E%2C%20%3Ci%3E308%3C%5C%2Fi%3E%2C%20S.%20421%26%23x2013%3B431.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jad.2022.04.061%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jad.2022.04.061%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prevalence%20of%20stressful%20life%20events%20and%20associations%20with%20symptoms%20of%20depression%2C%20anxiety%2C%20and%20post-traumatic%20stress%20disorder%20among%20people%20entering%20care%20for%20HIV%20in%20Cameroon%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20M.%22%2C%22lastName%22%3A%22Filiatreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20V.%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Dzudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20W.%22%2C%22lastName%22%3A%22Pence%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Wainberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Pefura-Yone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nsame%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Exposure%20to%20stressors%20increases%20the%20risk%20of%20mental%20health%20disorders.%20People%20living%20with%20HIV%20%28PLWH%29%20are%20particularly%20affected%20by%20poor%20mental%20health%20which%20can%20contribute%20to%20adverse%20HIV%20treatment%20outcomes.%20METHODS%3A%20We%20estimated%20the%20prevalence%20of%20recent%20stressful%20life%20events%20%28modified%20Life%20Events%20Survey%29%20among%20a%20cohort%20of%20PLWH%20entering%20HIV%20care%20at%20three%20public%20health%20care%20facilities%20in%20Cameroon%20and%20quantified%20the%20association%20of%20seven%20types%20of%20stressful%20life%20events%20with%20symptoms%20of%20depression%20%28Patient%20Health%20Questionnaire-9%20scores%3E9%29%2C%20anxiety%20%28General%20Anxiety%20Disorder-7%20scores%3E9%29%2C%20and%20PTSD%20%28PTSD%20Checklist%20for%20DSM-5%20scores%3E30%29%20using%20separate%20log-binomial%20regression%20models.%20RESULTS%3A%20Of%20426%20PLWH%20enrolling%20in%20care%2C%20a%20majority%20were%20women%20%2859%25%29%2C%20in%20relationships%20%2858%25%29%2C%20and%20aged%2021%20to%2039%20years%20%2858%25%29.%20Recent%20death%20of%20a%20family%20member%20%2839%25%29%20and%20severe%20illness%20of%20a%20family%20member%20%2834%25%29%20were%20the%20most%20commonly%20reported%20stressful%20life%20events.%20In%20multivariable%20analyses%2C%20more%20stressful%20life%20event%20types%2C%20a%20negative%20relationship%20change%2C%20death%20or%20illness%20of%20a%20friend%5C%2Ffamily%20member%2C%20experience%20of%20violence%2C%20work-related%20difficulties%2C%20and%20feeling%20unsafe%20in%20one%27s%20neighborhood%20were%20independently%20associated%20with%20at%20least%20one%20of%20the%20mental%20health%20outcomes%20assessed.%20The%20greatest%20magnitude%20of%20association%20was%20observed%20between%20work-related%20difficulties%20and%20PTSD%20%28adjusted%20prevalence%20ratio%3A%203.1%3B%2095%25%20confidence%20interval%3A%202.0-4.8%29.%20LIMITATIONS%3A%20Given%20the%20design%20of%20our%20study%2C%20findings%20are%20subject%20to%20recall%20and%20social%20desirability%20bias.%20CONCLUSIONS%3A%20Stressful%20life%20events%20were%20common%20among%20this%20population%20of%20PLWH%20entering%20care%20in%20Cameroon.%20Evidence-based%20interventions%20that%20improve%20coping%2C%20stress%20management%2C%20and%20mental%20health%20are%20needed.%22%2C%22date%22%3A%22Jul%201%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jad.2022.04.061%22%2C%22ISSN%22%3A%221573-2517%20%28Electronic%29%200165-0327%20%28Print%29%200165-0327%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZVWK2Q45%22%2C%22ZBJI578D%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A24%3A26Z%22%7D%7D%2C%7B%22key%22%3A%228N68RLVP%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Romo%20et%20al.%22%2C%22parsedDate%22%3A%222022-07%22%2C%22numChildren%22%3A10%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERomo%2C%20M.%20L.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrazier%2C%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMahambou-Nsonde%2C%20D.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EDe%20Waal%2C%20R.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ESekaggya-Wiltshire%2C%20C.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Real-world%20use%20and%20outcomes%20of%20dolutegravir-containing%20antiretroviral%20therapy%20in%20HIV%20and%20tuberculosis%20co-infection%3A%20a%20site%20survey%20and%20cohort%20study%20in%20sub-Saharan%20Africa.%20%3Ci%3EJ%20Int%20AIDS%20Soc%3C%5C%2Fi%3E%2C%20%3Ci%3E25%3C%5C%2Fi%3E%20%287%29%2C%20S.%20e25961.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.25961%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.25961%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Real-world%20use%20and%20outcomes%20of%20dolutegravir-containing%20antiretroviral%20therapy%20in%20HIV%20and%20tuberculosis%20co-infection%3A%20a%20site%20survey%20and%20cohort%20study%20in%20sub-Saharan%20Africa%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20L.%22%2C%22lastName%22%3A%22Romo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Mahambou-Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22De%20Waal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Sekaggya-Wiltshire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Chimbetete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20R.%22%2C%22lastName%22%3A%22Muyindike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Kunzekwenyika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Tiendrebeogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20A.%22%2C%22lastName%22%3A%22Muhairwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Dzudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%22%2C%22lastName%22%3A%22Rafael%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%20C.%22%2C%22lastName%22%3A%22Ezechi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20S.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aids%22%2C%22lastName%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Dolutegravir%20is%20being%20scaled%20up%20globally%20as%20part%20of%20antiretroviral%20therapy%20%28ART%29%2C%20but%20for%20people%20with%20HIV%20and%20tuberculosis%20co-infection%2C%20its%20use%20is%20complicated%20by%20a%20drug-drug%20interaction%20with%20rifampicin%20requiring%20an%20additional%20daily%20dose%20of%20dolutegravir.%20This%20represents%20a%20disadvantage%20over%20efavirenz%2C%20which%20does%20not%20have%20a%20major%20drug-drug%20interaction%20with%20rifampicin.%20We%20sought%20to%20describe%20HIV%20clinic%20practices%20for%20prescribing%20concomitant%20dolutegravir%20and%20rifampicin%2C%20and%20characterize%20virologic%20outcomes%20among%20patients%20with%20tuberculosis%20co-infection%20receiving%20dolutegravir%20or%20efavirenz.%20METHODS%3A%20Within%20the%20four%20sub-Saharan%20Africa%20regions%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20consortium%2C%20we%20conducted%20a%20site%20survey%20%282021%29%20and%20a%20cohort%20study%20%282015-2021%29.%20The%20cohort%20study%20used%20routine%20clinical%20data%20and%20included%20patients%20newly%20initiating%20or%20already%20receiving%20dolutegravir%20or%20efavirenz%20at%20the%20time%20of%20tuberculosis%20diagnosis.%20Patients%20were%20followed%20from%20tuberculosis%20diagnosis%20until%20viral%20suppression%20%28%3C1000%20copies%5C%2Fml%29%2C%20a%20competing%20event%20%28switching%20ART%20regimen%3B%20loss%20to%20program%5C%2Fdeath%29%20or%20administrative%20censoring%20at%2012%20months.%20RESULTS%3A%20In%20the%20survey%2C%2086%20of%2090%20%2896%25%29%20HIV%20clinics%20in%2018%20countries%20reported%20prescribing%20dolutegravir%20to%20patients%20who%20were%20receiving%20rifampicin%20as%20part%20of%20tuberculosis%20treatment%2C%20with%2077%20%2890%25%29%20reporting%20that%20they%20use%20twice-daily%20dosing%20of%20dolutegravir%2C%20of%20which%2074%20%2896%25%29%20reported%20having%2050%20mg%20tablets%20available%20to%20accommodate%20twice-daily%20dosing.%20The%20cohort%20study%20included%203563%20patients%20in%2011%20countries%2C%20with%2067%25%20newly%20or%20recently%20initiating%20ART.%20Among%20patients%20receiving%20dolutegravir%20%28n%20%3D%20465%29%2C%20the%20cumulative%20incidence%20of%20viral%20suppression%20was%2058.9%25%20%2895%25%20confidence%20interval%20%5BCI%5D%3A%2054.3-63.3%25%29%2C%20switching%20ART%20regimen%20was%204.1%25%20%2895%25%20CI%3A%202.6-6.2%25%29%20and%20loss%20to%20program%5C%2Fdeath%20was%2023.4%25%20%2895%25%20CI%3A%2019.7-27.4%25%29.%20Patients%20receiving%20dolutegravir%20had%20improved%20viral%20suppression%20compared%20with%20patients%20receiving%20efavirenz%20who%20had%20a%20tuberculosis%20diagnosis%20before%20site%20dolutegravir%20availability%20%28adjusted%20subdistribution%20hazard%20ratio%20%5BaSHR%5D%3A%201.47%2C%2095%25%20CI%3A%201.28-1.68%29%20and%20after%20site%20dolutegravir%20availability%20%28aSHR%201.28%2C%2095%25%20CI%3A%201.08-1.51%29.%20CONCLUSIONS%3A%20At%20a%20programmatic%20level%2C%20dolutegravir%20was%20being%20widely%20prescribed%20in%20sub-Saharan%20Africa%20for%20people%20with%20HIV%20and%20tuberculosis%20co-infection%20with%20a%20dose%20adjustment%20for%20the%20drug-drug%20interaction%20with%20rifampicin.%20Despite%20this%20more%20complex%20regimen%2C%20our%20cohort%20study%20revealed%20that%20dolutegravir%20did%20not%20negatively%20impact%20viral%20suppression.%22%2C%22date%22%3A%22Jul%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25961%22%2C%22ISSN%22%3A%221758-2652%20%28Electronic%29%201758-2652%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A25%3A35Z%22%7D%7D%2C%7B%22key%22%3A%22I7VS56EA%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lewis%20et%20al.%22%2C%22parsedDate%22%3A%222022-07%22%2C%22numChildren%22%3A16%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ELewis%2C%20J.%20T.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EStephens%2C%20J.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMusick%2C%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrown%2C%20S.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMalateste%2C%20K.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20The%20IeDEA%20harmonist%20data%20toolkit%3A%20A%20data%20quality%20and%20data%20sharing%20solution%20for%20a%20global%20HIV%20research%20consortium.%20%3Ci%3EJ%20Biomed%20Inform%3C%5C%2Fi%3E%2C%20%3Ci%3E131%3C%5C%2Fi%3E%2C%20S.%20104110.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbi.2022.104110%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jbi.2022.104110%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20IeDEA%20harmonist%20data%20toolkit%3A%20A%20data%20quality%20and%20data%20sharing%20solution%20for%20a%20global%20HIV%20research%20consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20T.%22%2C%22lastName%22%3A%22Lewis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Stephens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Ha%20Dao%20Ostinelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Maxwell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Jayathilake%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Q.%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Hogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20E.%20A.%22%2C%22lastName%22%3A%22on%20the%20behalf%20of%20le%22%7D%5D%2C%22abstractNote%22%3A%22We%20describe%20the%20design%2C%20implementation%2C%20and%20impact%20of%20a%20data%20harmonization%2C%20data%20quality%20checking%2C%20and%20dynamic%20report%20generation%20application%20in%20an%20international%20observational%20HIV%20research%20network.%20The%20IeDEA%20Harmonist%20Data%20Toolkit%20is%20a%20web-based%20application%20written%20in%20the%20open%20source%20programming%20language%20R%2C%20employs%20the%20R%5C%2FShiny%20and%20RMarkdown%20packages%2C%20and%20leverages%20the%20REDCap%20data%20collection%20platform%20for%20data%20model%20definition%20and%20user%20authentication.%20The%20Toolkit%20performs%20data%20quality%20checks%20on%20uploaded%20datasets%2C%20checks%20for%20conformance%20with%20the%20network%27s%20common%20data%20model%2C%20displays%20the%20results%20both%20interactively%20and%20in%20downloadable%20reports%2C%20and%20stores%20approved%20datasets%20in%20secure%20cloud%20storage%20for%20retrieval%20by%20the%20requesting%20investigator.%20Including%20stakeholders%20and%20users%20in%20the%20design%20process%20was%20key%20to%20the%20successful%20adoption%20of%20the%20application.%20A%20survey%20of%20regional%20data%20managers%20as%20well%20as%20initial%20usage%20metrics%20indicate%20that%20the%20Toolkit%20saves%20time%20and%20results%20in%20improved%20data%20quality%2C%20with%20a%2061%25%20mean%20reduction%20in%20the%20number%20of%20error%20records%20in%20a%20dataset.%20The%20generalized%20application%20design%20allows%20the%20Toolkit%20to%20be%20easily%20adapted%20to%20other%20research%20networks.%22%2C%22date%22%3A%22Jul%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jbi.2022.104110%22%2C%22ISSN%22%3A%221532-0480%20%28Electronic%29%201532-0464%20%28Print%29%201532-0464%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A30%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22IBITJURF%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lewis%20et%20al.%22%2C%22parsedDate%22%3A%222022-06-06%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ELewis%2C%20J.%20T.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrazier%2C%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKatz%2C%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ENash%2C%20D.%3C%5C%2Fspan%3E%20%26amp%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EDuda%2C%20S.%20N.%3C%5C%2Fspan%3E%20%282022%29.%20A%20Method%20for%20Generating%20Dashboard%20Aggregations%20in%20an%20International%20HIV%20Consortium.%20%3Ci%3EStud%20Health%20Technol%20Inform%3C%5C%2Fi%3E%2C%20%3Ci%3E290%3C%5C%2Fi%3E%2C%20S.%201048%26%23x2013%3B1049.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3233%5C%2FSHTI220261%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3233%5C%2FSHTI220261%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20Method%20for%20Generating%20Dashboard%20Aggregations%20in%20an%20International%20HIV%20Consortium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20T.%22%2C%22lastName%22%3A%22Lewis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Katz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%5D%2C%22abstractNote%22%3A%22Online%20dashboards%20are%20valuable%20tools%20for%20gaining%20insights%20about%20population%20health%20metrics%20of%20interest%20and%20for%20disseminating%20data%20collected%20through%20research%20networks.%20The%20process%20of%20aggregating%20data%20from%20separate%20databases%20for%20use%20in%20online%20dashboards%2C%20while%20also%20ensuring%20data%20quality%2C%20is%20complex.%20We%20describe%20a%20method%20for%20integrating%20HIV%20dashboard%20aggregation%20scripts%20into%20an%20existing%20web-based%20data%20quality%20checking%20application%20and%20leveraging%20REDCap%20to%20store%20aggregated%20metrics.%22%2C%22date%22%3A%22Jun%206%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.3233%5C%2FSHTI220261%22%2C%22ISSN%22%3A%221879-8365%20%28Electronic%29%200926-9630%20%28Print%29%200926-9630%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A12%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22V86ICMTD%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Antimycobacterial%20Susceptibility%20Testing%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A16%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAntimycobacterial%20Susceptibility%20Testing%2C%20Group%3C%5C%2Fspan%3E%20%282022%29.%20Updating%20the%20approaches%20to%20define%20susceptibility%20and%20resistance%20to%20anti-tuberculosis%20agents%3A%20implications%20for%20diagnosis%20and%20treatment.%20%3Ci%3EEur%20Respir%20J%3C%5C%2Fi%3E%2C%20%3Ci%3E59%3C%5C%2Fi%3E%20%284%29%2C%20S.%202200166.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00166-2022%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00166-2022%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Updating%20the%20approaches%20to%20define%20susceptibility%20and%20resistance%20to%20anti-tuberculosis%20agents%3A%20implications%20for%20diagnosis%20and%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Group%22%2C%22lastName%22%3A%22Antimycobacterial%20Susceptibility%20Testing%22%7D%5D%2C%22abstractNote%22%3A%22Inappropriately%20high%20breakpoints%20have%20resulted%20in%20systematic%20false-susceptible%20AST%20results%20to%20anti-TB%20drugs.%20MIC%2C%20PK%5C%2FPD%20and%20clinical%20outcome%20data%20should%20be%20combined%20when%20setting%20breakpoints%20to%20minimise%20the%20emergence%20and%20spread%20of%20antimicrobial%20resistance.%20https%3A%5C%2F%5C%2Fbit.ly%5C%2F3i43wb6%5CnApproximately%2085%20000%20deaths%20globally%20in%202019%20were%20due%20to%20drug-resistant%20tuberculosis%20%28TB%29%2C%20which%20corresponds%20to%207%25%20of%20global%20deaths%20attributable%20to%20bacterial%20antimicrobial%20resistance%20%5B1%5D.%20Yet%20concerns%20have%20been%20mounting%20that%20drug-resistant%20TB%20was%20being%20underestimated%20because%20the%20approaches%20to%20define%20susceptibility%20and%20resistance%20to%20anti-TB%20agents%20had%20not%20kept%20up%20with%20those%20used%20for%20other%20major%20bacterial%20pathogens%20%5B2-9%5D.%20Here%2C%20we%20outline%20the%20recent%2C%20evidence-based%20initiatives%20spearheaded%20by%20the%20World%20Health%20Organization%20%28WHO%29%20and%20others%20to%20update%20breakpoints%20%28traditionally%20referred%20to%20as%20critical%20concentrations%20%28CCs%29%29%20that%20are%20used%20for%20phenotypic%20antimicrobial%20susceptibility%20testing%20%28AST%29%2C%20also%20called%20drug%20susceptibility%20testing%20in%20the%20TB%20literature.%5Cneng%22%2C%22date%22%3A%22Apr%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.00166-2022%22%2C%22ISSN%22%3A%221399-3003%20%28Electronic%29%200903-1936%20%28Print%29%200903-1936%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A32%3A48Z%22%7D%7D%2C%7B%22key%22%3A%227LE2GH88%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Justice%20et%20al.%22%2C%22parsedDate%22%3A%222022-04%22%2C%22numChildren%22%3A16%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJustice%2C%20A.%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EGoetz%2C%20M.%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EStewart%2C%20C.%20N.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EHogan%2C%20B.%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EHumes%2C%20E.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Delayed%20presentation%20of%20HIV%20among%20older%20individuals%3A%20a%20growing%20problem.%20%3Ci%3ELancet%20HIV%3C%5C%2Fi%3E%2C%20%3Ci%3E9%3C%5C%2Fi%3E%20%284%29%2C%20S.%20e269%26%23x2013%3Be280.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2352-3018%2822%2900003-0%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS2352-3018%2822%2900003-0%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Delayed%20presentation%20of%20HIV%20among%20older%20individuals%3A%20a%20growing%20problem%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20C.%22%2C%22lastName%22%3A%22Justice%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20B.%22%2C%22lastName%22%3A%22Goetz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20N.%22%2C%22lastName%22%3A%22Stewart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20C.%22%2C%22lastName%22%3A%22Hogan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Humes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20M.%22%2C%22lastName%22%3A%22Luz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20L.%22%2C%22lastName%22%3A%22Castilho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Yiannoutsos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Malateste%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Jaquet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Cornell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Shamu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Rajasuriar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Jiamsakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20N.%22%2C%22lastName%22%3A%22Althoff%22%7D%5D%2C%22abstractNote%22%3A%22Late%20presentation%20for%20care%20is%20a%20major%20impediment%20to%20the%20prevention%20and%20effective%20treatment%20of%20HIV%20infection.%20Older%20individuals%20are%20at%20increased%20risk%20of%20late%20presentation%2C%20represent%20a%20growing%20proportion%20of%20people%20with%20late%20presentation%2C%20and%20might%20require%20interventions%20tailored%20to%20their%20age%20group.%20We%20provide%20a%20summary%20of%20the%20literature%20published%20globally%20between%202016-21%20%28reporting%20data%20from%201984-2018%29%20and%20quantify%20the%20association%20of%20age%20with%20delayed%20presentation.%20Using%20the%20most%20common%20definitions%20of%20late%20presentation%20and%20older%20age%20from%20these%20earlier%20studies%2C%20we%20update%20this%20work%20with%20data%20from%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium%2C%20focusing%20on%20data%20from%202000-19%2C%20encompassing%20four%20continents.%20Finally%2C%20we%20consider%20how%20late%20presentation%20among%20older%20individuals%20might%20be%20more%20effectively%20addressed%20as%20electronic%20medical%20records%20become%20widely%20adopted.%22%2C%22date%22%3A%22Apr%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS2352-3018%2822%2900003-0%22%2C%22ISSN%22%3A%222352-3018%20%28Electronic%29%202405-4704%20%28Print%29%202352-3018%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A18%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22MTA7D26V%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EParcesepe%2C%20A.%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERemch%2C%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EDzudie%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAjeh%2C%20R.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ENash%2C%20D.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Depressive%20Symptoms%2C%20Gender%2C%20Disclosure%2C%20and%20HIV%20Care%20Stage%20Among%20People%20Living%20with%20HIV%20in%20Cameroon.%20%3Ci%3EAIDS%20Behav%3C%5C%2Fi%3E%2C%20%3Ci%3E26%3C%5C%2Fi%3E%20%283%29%2C%20S.%20651%26%23x2013%3B661.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10461-021-03425-3%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs10461-021-03425-3%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Depressive%20Symptoms%2C%20Gender%2C%20Disclosure%2C%20and%20HIV%20Care%20Stage%20Among%20People%20Living%20with%20HIV%20in%20Cameroon%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Remch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Dzudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Pefura-Yone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Lancaster%22%7D%5D%2C%22abstractNote%22%3A%22Depression%20is%20associated%20with%20suboptimal%20HIV%20care%20outcomes.%20Little%20is%20known%20about%20the%20extent%20to%20which%20the%20prevalence%20of%20depressive%20symptoms%20varies%20across%20the%20HIV%20care%20continuum.%20Also%2C%20the%20relationship%20among%20gender%2C%20HIV%20disclosure%2C%20HIV%20care%20stage%2C%20and%20depressive%20symptoms%20in%20PLWH%20remains%20poorly%20understood.%20We%20analyzed%20cross-sectional%20data%20from%2012%2C507%20PLWH%20at%20enrollment%20in%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20Cameroon%20between%202016%20and%202020.%20Recent%20depressive%20symptoms%20were%20assessed%20using%20the%20Patient%20Health%20Questionnaire-2%20%28PHQ-2%29.%20A%20score%20of%20three%20or%20greater%20on%20the%20PHQ-2%20was%20considered%20indicative%20of%20likely%20major%20depressive%20disorder.%20We%20estimated%20the%20prevalence%20of%20depressive%20symptoms%20across%20three%20stages%20of%20HIV%20care%3A%20those%20not%20yet%20on%20antiretroviral%20therapy%20%28ART%29%2C%20recent%20ART%20initiators%20%28ART%20initiation%20%3C%5C%2F%3D%2030%20days%20prior%29%2C%20and%20ART%20users%20%28ART%20initiation%20%3E%2030%20days%20prior%29.%20Adjusted%20prevalence%20differences%20%28aPD%29%20of%20depressive%20symptoms%20were%20estimated%20comparing%20recent%20ART%20initiators%20and%20ART%20users.%20Disclosure%20and%20gender%20were%20examined%20as%20effect%20measure%20modifiers%20of%20the%20relationship%20between%20HIV%20care%20stage%20and%20depressive%20symptoms.%20The%20prevalence%20of%20depressive%20symptoms%20was%2011.9%25%2C%2022.0%25%2C%20and%208.7%25%20among%20PLWH%20not%20yet%20on%20ART%2C%20recent%20ART%20initiators%2C%20and%20ART%20users%2C%20respectively.%20ART%20users%20had%20significantly%20lower%20prevalence%20of%20depressive%20symptoms%20compared%20to%20recent%20ART%20initiators%20%28aPD%20-%200.09%20%5B95%25%20CI%20-%200.11%2C%20-%200.08%5D%29.%20Neither%20gender%20nor%20HIV%20disclosure%20modified%20the%20effect%20measure%20of%20the%20relationship%20between%20HIV%20care%20stage%20and%20depressive%20symptoms.%20Depressive%20symptoms%20were%20commonly%20reported%20among%20this%20group%20of%20PLWH%20and%20were%20associated%20with%20recent%20ART%20initiation.%20Integration%20of%20screening%20and%20treatment%20of%20depression%20into%20HIV%20care%20should%20be%20prioritized%20and%20may%20be%20particularly%20relevant%20for%20PLWH%20initiating%20ART.%22%2C%22date%22%3A%22Mar%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs10461-021-03425-3%22%2C%22ISSN%22%3A%221573-3254%20%28Electronic%29%201090-7165%20%28Print%29%201090-7165%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZVWK2Q45%22%2C%22ZBJI578D%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A41%3A11Z%22%7D%7D%2C%7B%22key%22%3A%22JSS8DS84%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Collaborative%20Initiative%20for%20Paediatric%20et%20al.%22%2C%22parsedDate%22%3A%222022-03%22%2C%22numChildren%22%3A14%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECollaborative%20Initiative%20for%20Paediatric%2C%20H.%20I.%20V.%20Education%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EResearch%20Global%20Cohort%2C%20Collaboration%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EJesson%2C%20J.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECrichton%2C%20S.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EQuartagno%2C%20M.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Growth%20and%20CD4%20patterns%20of%20adolescents%20living%20with%20perinatally%20acquired%20HIV%20worldwide%2C%20a%20CIPHER%20cohort%20collaboration%20analysis.%20%3Ci%3EJ%20Int%20AIDS%20Soc%3C%5C%2Fi%3E%2C%20%3Ci%3E25%3C%5C%2Fi%3E%20%283%29%2C%20S.%20e25871.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.25871%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.25871%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Growth%20and%20CD4%20patterns%20of%20adolescents%20living%20with%20perinatally%20acquired%20HIV%20worldwide%2C%20a%20CIPHER%20cohort%20collaboration%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%20I.%20V.%20Education%22%2C%22lastName%22%3A%22Collaborative%20Initiative%20for%20Paediatric%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Collaboration%22%2C%22lastName%22%3A%22Research%20Global%20Cohort%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Jesson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Crichton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Quartagno%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20J.%22%2C%22lastName%22%3A%22Abrams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Chokephaibulkit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Le%20Coeur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20H.%22%2C%22lastName%22%3A%22Ake-Assi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Paul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Vreeman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20A.%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Ben-Farhat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Van%20Dyke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Judd%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Mofenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Vicari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Seage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20G.%22%2C%22lastName%22%3A%22Bekker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Essajee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Gibb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Penazzato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%20J.%22%2C%22lastName%22%3A%22Collins%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Slogrove%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Powis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Matshaba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Thahane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Nyasulu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Lukhele%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Mwita%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Kekitiinwa-Rukyalekere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Wanless%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Goetghebuer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Thorne%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Warszawski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Galli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20M.%20C.%22%2C%22lastName%22%3A%22van%20Rossum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Giaquinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Marczynska%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Marques%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Prata%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Ene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Okhonskaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Navarro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Frick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Naver%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Kahlert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Volokha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Chappell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20W.%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Marcelin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Succi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20H.%22%2C%22lastName%22%3A%22Sohn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Kariminia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Edmonds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Lyamuya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20A.%22%2C%22lastName%22%3A%22Ogalo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20A.%22%2C%22lastName%22%3A%22Odhiambo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20D.%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bolton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Muhairwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Tweya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Sylla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22D%27Almeida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Renner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20J.%22%2C%22lastName%22%3A%22Abzug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Oleske%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Purswani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Teasdale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Nuwagaba-Biribonwoha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Goodall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Leroy%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Adolescents%20living%20with%20HIV%20are%20subject%20to%20multiple%20co-morbidities%2C%20including%20growth%20retardation%20and%20immunodeficiency.%20We%20describe%20growth%20and%20CD4%20evolution%20during%20adolescence%20using%20data%20from%20the%20Collaborative%20Initiative%20for%20Paediatric%20HIV%20Education%20and%20Research%20%28CIPHER%29%20global%20project.%20METHODS%3A%20Data%20were%20collected%20between%201994%20and%202015%20from%2011%20CIPHER%20networks%20worldwide.%20Adolescents%20with%20perinatally%20acquired%20HIV%20infection%20%28APH%29%20who%20initiated%20antiretroviral%20therapy%20%28ART%29%20before%20age%2010%20years%2C%20with%20at%20least%20one%20height%20or%20CD4%20count%20measurement%20while%20aged%2010-17%20years%2C%20were%20included.%20Growth%20was%20measured%20using%20height-for-age%20Z-scores%20%28HAZ%2C%20stunting%20if%20%3C-2%20SD%2C%20WHO%20growth%20charts%29.%20Linear%20mixed-effects%20models%20were%20used%20to%20study%20the%20evolution%20of%20each%20outcome%20between%20ages%2010%20and%2017.%20For%20growth%2C%20sex-specific%20models%20with%20fractional%20polynomials%20were%20used%20to%20model%20non-linear%20relationships%20for%20age%20at%20ART%20initiation%2C%20HAZ%20at%20age%2010%20and%20time%2C%20defined%20as%20current%20age%20from%2010%20to%2017%20years%20of%20age.%20RESULTS%3A%20A%20total%20of%2020%2C939%20and%2019%2C557%20APH%20were%20included%20for%20the%20growth%20and%20CD4%20analyses%2C%20respectively.%20Half%20were%20females%2C%20two-thirds%20lived%20in%20East%20and%20Southern%20Africa%2C%20and%20median%20age%20at%20ART%20initiation%20ranged%20from%20%3C3%20years%20in%20North%20America%20and%20Europe%20to%20%3E7%20years%20in%20sub-Saharan%20African%20regions.%20At%20age%2010%2C%20stunting%20ranged%20from%206%25%20in%20North%20America%20and%20Europe%20to%2039%25%20in%20the%20Asia-Pacific%3B%2019%25%20overall%20had%20CD4%20counts%20%3C500%20cells%5C%2Fmm%283%29%20.%20Across%20adolescence%2C%20higher%20HAZ%20was%20observed%20in%20females%20and%20among%20those%20in%20high-income%20countries.%20APH%20with%20stunting%20at%20age%2010%20and%20those%20with%20late%20ART%20initiation%20%28after%20age%205%29%20had%20the%20largest%20HAZ%20gains%20during%20adolescence%2C%20but%20these%20gains%20were%20insufficient%20to%20catch-up%20with%20non-stunted%2C%20early%20ART-treated%20adolescents.%20From%20age%2010%20to%2016%20years%2C%20mean%20CD4%20counts%20declined%20from%20768%20to%20607%20cells%5C%2Fmm%283%29%20.%20This%20decline%20was%20observed%20across%20all%20regions%2C%20in%20males%20and%20females.%20CONCLUSIONS%3A%20Growth%20patterns%20during%20adolescence%20differed%20substantially%20by%20sex%20and%20region%2C%20while%20CD4%20patterns%20were%20similar%2C%20with%20an%20observed%20CD4%20decline%20that%20needs%20further%20investigation.%20Early%20diagnosis%20and%20timely%20initiation%20of%20treatment%20in%20early%20childhood%20to%20prevent%20growth%20retardation%20and%20immunodeficiency%20are%20critical%20to%20improving%20APH%20growth%20and%20CD4%20outcomes%20by%20the%20time%20they%20reach%20adulthood.%22%2C%22date%22%3A%22Mar%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25871%22%2C%22ISSN%22%3A%221758-2652%20%28Electronic%29%201758-2652%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A20%3A13Z%22%7D%7D%2C%7B%22key%22%3A%222Z5WU79P%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shaikh%20et%20al.%22%2C%22parsedDate%22%3A%222022-02-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EShaikh%2C%20K.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBhondoekhan%2C%20F.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EHaberlen%2C%20S.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ENakanishi%2C%20R.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERoy%2C%20S.%20K.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Coronary%20artery%20plaque%20progression%20and%20cardiovascular%20risk%20scores%20in%20men%20with%20and%20without%20HIV-infection.%20%3Ci%3EAIDS%3C%5C%2Fi%3E%2C%20%3Ci%3E36%3C%5C%2Fi%3E%20%282%29%2C%20S.%20215%26%23x2013%3B224.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000003093%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1097%5C%2FQAD.0000000000003093%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Coronary%20artery%20plaque%20progression%20and%20cardiovascular%20risk%20scores%20in%20men%20with%20and%20without%20HIV-infection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Shaikh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Bhondoekhan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Haberlen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Nakanishi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20K.%22%2C%22lastName%22%3A%22Roy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%20M.%22%2C%22lastName%22%3A%22Alla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%20T.%22%2C%22lastName%22%3A%22Brown%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Osawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Almeida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Rahmani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Nezarat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Sheidaee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Jayawardena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Hathiramani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20J.%22%2C%22lastName%22%3A%22Palella%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Witt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Ahmad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Kingsley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20S.%22%2C%22lastName%22%3A%22Post%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20J.%22%2C%22lastName%22%3A%22Budoff%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20The%20aim%20of%20this%20study%20was%20to%20assess%20the%20association%20of%20cardiovascular%20disease%20%28CVD%29%20risk%20scores%20and%20coronary%20artery%20plaque%20%28CAP%29%20progression%20in%20HIV-infected%20participants.%20METHODS%3A%20We%20studied%20men%20with%20and%20without%20HIV-infection%20enrolled%20in%20the%20Multicenter%20AIDS%20Cohort%20Study%20%28MACS%29%20CVD%20study.%20CAP%20at%20baseline%20and%20follow-up%20was%20assessed%20with%20cardiac%20computed%20tomography%20angiography%20%28CCTA%29.%20We%20examined%20the%20association%20between%20baseline%20risk%20scores%20including%20pooled%20cohort%20equation%20%28PCE%29%2C%20Framingham%20risk%20score%20%28FRS%29%2C%20and%20Data%20collect%20of%20Adverse%20effects%20of%20anti-HIV%20drugs%20equation%20%28D%3AA%3AD%29%20and%20CAP%20progression.%20RESULTS%3A%20We%20studied%20495%20men%20%28211%20HIV-uninfected%2C%20284%20HIV-infected%29.%20The%20adjusted%20odds%20ratio%20%28aOR%29%20of%20total%20plaque%20volume%20%28TPV%29%20and%20noncalcified%20plaque%20volume%20%28NCPV%29%20progression%20in%20the%20highest%20relative%20to%20lowest%20tertile%20was%209.4%20%5B95%25%20confidence%20interval%20%2895%25%20CI%29%202.4-12.1%2C%20P%20%3C%200.001%29%5D%20and%207.7%20%2895%25%20CI%203.1-19.1%2C%20P%20%3C%200.001%29%20times%20greater%2C%20respectively%2C%20among%20HIV-uninfected%20men%20in%20the%20PCE%20atherosclerotic%20cardiovascular%20disease%20%28ASCVD%29%20high%20vs.%20low-risk%20category.%20Among%20HIV-infected%20men%2C%20the%20association%20for%20TPV%20and%20NCPV%20progression%20for%20the%20same%20PCE%20risk%20categories%2C%20odds%20ratio%20%28OR%29%202.8%20%2895%25%20CI%201.4-5.8%2C%20P%20%3C%200.01%29%20and%20OR%202.4%20%2895%25%20CI%201.2-4.8%2C%20P%20%3C%200.05%29%2C%20respectively%20%28P%20values%20for%20interaction%20by%20HIV%20%3D%200.02%20and%200.08%2C%20respectively%29.%20Similar%20results%20were%20seen%20for%20the%20FRS%20risk%20scores.%20Among%20HIV-uninfected%20men%2C%20PCE%20high%20risk%20category%20identified%20the%20highest%20proportion%20of%20men%20with%20plaque%20progression%20in%20the%20highest%20tertile%2C%20although%20in%20HIV-infected%20men%2C%20high-risk%20category%20by%20D%3AA%3AD%20identified%20the%20greatest%20percentage%20of%20men%20with%20plaque%20progression%20albeit%20with%20lower%20specificity%20than%20FRS%20and%20PCE.%20CONCLUSION%3A%20PCE%20and%20FRS%20categories%20predict%20CAP%20progression%20better%20in%20HIV-uninfected%20than%20in%20HIV-infected%20men.%20Improved%20CVD%20risk%20scores%20are%20needed%20to%20identify%20high-risk%20HIV-infected%20men%20for%20more%20aggressive%20CVD%20risk%20prevention%20strategies.%22%2C%22date%22%3A%22Feb%201%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1097%5C%2FQAD.0000000000003093%22%2C%22ISSN%22%3A%221473-5571%20%28Electronic%29%200269-9370%20%28Print%29%200269-9370%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22ZBJI578D%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A40%3A12Z%22%7D%7D%2C%7B%22key%22%3A%222W7XGEKC%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zotova%20et%20al.%22%2C%22parsedDate%22%3A%222022-02%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EZotova%2C%20N.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFamiliar%2C%20I.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKawende%2C%20B.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EKasindi%2C%20F.%20L.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERavelomanana%2C%20N.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20HIV%20disclosure%20and%20depressive%20symptoms%20among%20pregnant%20women%20living%20with%20HIV%3A%20a%20cross-sectional%20study%20in%20the%20Democratic%20Republic%20of%20Congo.%20%3Ci%3EJ%20Int%20AIDS%20Soc%3C%5C%2Fi%3E%2C%20%3Ci%3E25%3C%5C%2Fi%3E%20%282%29%2C%20S.%20e25865.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.25865%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.25865%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22HIV%20disclosure%20and%20depressive%20symptoms%20among%20pregnant%20women%20living%20with%20HIV%3A%20a%20cross-sectional%20study%20in%20the%20Democratic%20Republic%20of%20Congo%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Zotova%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22I.%22%2C%22lastName%22%3A%22Familiar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Kawende%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%20L.%22%2C%22lastName%22%3A%22Kasindi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Ravelomanana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20E.%22%2C%22lastName%22%3A%22Lancaster%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Kaba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Babakazo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Disclosure%20of%20one%27s%20HIV%20status%20may%20decrease%20depression%20and%20improve%20the%20quality%20of%20life%20among%20people%20living%20with%20HIV.%20However%2C%20there%20is%20mixed%20evidence%20on%20the%20impact%20of%20disclosure%20to%20partners%20for%20pregnant%20women%20living%20with%20HIV%20%28WLHIV%29%20in%20areas%20of%20intersecting%20social%20concerns%20over%20disclosure%20and%20high%20prevalence%20of%20intimate%20partner%20violence%20%28IPV%29.%20We%20assessed%20the%20association%20between%20HIV%20disclosure%20and%20depressive%20symptoms%20among%20pregnant%20WLHIV%20in%20the%20Democratic%20Republic%20of%20Congo%20%28DRC%29%20and%20examined%20whether%20the%20knowledge%20of%20partner%27s%20status%20or%20recent%20IPV%20modified%20this%20association.%20METHODS%3A%20We%20utilized%20data%20from%20participants%20enrolled%20in%20a%20trial%20to%20evaluate%20the%20effect%20of%20continuous%20quality%20interventions%20on%20long-term%20therapy%20outcomes%20among%20HIV-positive%20pregnant%20and%20breastfeeding%20women%20in%20DRC%20%28NCT03048669%29.%20Only%20pregnant%20women%20%28n%20%3D%201392%29%20were%20included%20in%20this%20cross-sectional%20analysis.%20Between%20November%202016%20and%20June%202019%2C%20enrolled%20participants%20completed%20a%20survey%20that%20included%20the%20Patient%20Health%20Questionnaire-9%20%28PHQ-9%29%20to%20screen%20recent%20depressive%20symptoms%2C%20questions%20about%20disclosure%2C%20knowledge%20of%20partner%27s%20status%20and%20IPV.%20We%20used%20linear%20models%20to%20calculate%20crude%20and%20adjusted%20mean%20differences%20%28MDs%29%20between%20disclosure%20and%20depressive%20symptoms.%20All%20analyses%20were%20stratified%20by%20timing%20of%20HIV%20diagnosis.%20RESULTS%3A%20Disclosure%20was%20higher%20among%20participants%20diagnosed%20prior%20to%20current%20pregnancy%20%2841%25%20to%20their%20partners%20and%2024%25%20to%20family%2C%20friends%20or%20others%29%20relative%20to%20those%20diagnosed%20during%20current%20pregnancy%20%2821%25%20to%20partners%20and%2012%25%20to%20family%29.%20About%20one-quarter%20of%20women%20reported%20any%20type%20of%20IPV%20in%20the%20past%2012%20months.%20Disclosure%20to%20a%20partner%20was%20associated%20with%20lower%20depressive%20symptoms%20among%20women%20diagnosed%20prior%20to%20current%20pregnancy%20%28MD%20-0.55%3B%2095%25%20CI%3A%20-1.06%2C%20-0.04%29%20but%20the%20opposite%20was%20observed%20among%20those%20diagnosed%20during%20current%20pregnancy%20%28MD%200.5%3B%2095%25%20CI%3A%20-0.4%2C%201.4%29.%20Adjustment%20for%20IPV%2C%20knowledge%20of%20partner%27s%20status%2C%20age%2C%20number%20of%20living%20children%20and%20primigravidae%20did%20not%20change%20MDs%20substantially.%20CONCLUSIONS%3A%20Women%20in%20our%20sample%20mostly%20disclosed%20to%20partners%20despite%20high%20IPV%20burden.%20The%20observed%20association%20between%20disclosure%20to%20partners%20and%20lower%20depressive%20symptoms%20among%20women%20diagnosed%20prior%20to%20current%20pregnancy%20is%20consistent%20with%20cross-national%20evidence.%20A%20prospective%20study%20among%20pregnant%20WLHIV%20is%20needed%20to%20examine%20longitudinal%20effects%20of%20HIV%20status%20disclosure.%22%2C%22date%22%3A%22Feb%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.25865%22%2C%22ISSN%22%3A%221758-2652%20%28Electronic%29%201758-2652%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22ZBJI578D%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A20%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22IJPACHVY%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sam-Agudu%20et%20al.%22%2C%22parsedDate%22%3A%222022-02%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ESam-Agudu%2C%20N.%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EQuakyi%2C%20N.%20K.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMasekela%2C%20R.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EZumla%2C%20A.%3C%5C%2Fspan%3E%20%26amp%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ENachega%2C%20J.%20B.%3C%5C%2Fspan%3E%20%282022%29.%20Children%20and%20adolescents%20in%20African%20countries%20should%20also%20be%20vaccinated%20for%20COVID-19.%20%3Ci%3EBMJ%20Glob%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E7%3C%5C%2Fi%3E%20%282%29%2C%20S.%20e008315.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2021-008315%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2021-008315%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Children%20and%20adolescents%20in%20African%20countries%20should%20also%20be%20vaccinated%20for%20COVID-19%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20A.%22%2C%22lastName%22%3A%22Sam-Agudu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20K.%22%2C%22lastName%22%3A%22Quakyi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Masekela%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Zumla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20B.%22%2C%22lastName%22%3A%22Nachega%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Feb%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjgh-2021-008315%22%2C%22ISSN%22%3A%222059-7908%20%28Print%29%202059-7908%20%28Electronic%29%202059-7908%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22ZBJI578D%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A39%3A04Z%22%7D%7D%2C%7B%22key%22%3A%22DSMSKHQ4%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Thompson%20et%20al.%22%2C%22parsedDate%22%3A%222022-01-26%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EThompson%2C%20P.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMpody%2C%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ESayre%2C%20W.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERigney%2C%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ETabala%2C%20M.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Hepatitis%20C%20prevalence%20and%20quality%20of%20health%20services%20among%20HIV-positive%20mothers%20in%20the%20Democratic%20Republic%20of%20the%20Congo.%20%3Ci%3ESci%20Rep%3C%5C%2Fi%3E%2C%20%3Ci%3E12%3C%5C%2Fi%3E%20%281%29%2C%20S.%201384.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-022-05014-3%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-022-05014-3%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hepatitis%20C%20prevalence%20and%20quality%20of%20health%20services%20among%20HIV-positive%20mothers%20in%20the%20Democratic%20Republic%20of%20the%20Congo%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Thompson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Mpody%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sayre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Rigney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Tabala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20L.%20R.%22%2C%22lastName%22%3A%22Ravelomanana%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Malongo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Kawende%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Behets%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Okitolonda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22Cqi-Pmtct%20study%20team%22%7D%5D%2C%22abstractNote%22%3A%22Hepatitis%20C%20virus%20%28HCV%29%20contributes%20to%20liver-related%20morbidity%20and%20mortality%20throughout%20Africa%20despite%20effective%20antivirals.%20HCV%20is%20endemic%20in%20the%20Democratic%20Republic%20of%20the%20Congo%20%28DRC%29%20but%20data%20on%20HCV%5C%2FHIV%20co-infection%20in%20pregnancy%20is%20limited.%20We%20estimated%20the%20prevalence%20of%20and%20risk%20factors%20for%20HCV%5C%2FHIV%20co-infection%20among%20pregnant%20women%20in%20the%20Kinshasa%20province%20of%20the%20DRC.%20This%20cross-sectional%20study%20was%20conducted%20as%20a%20sub-study%20of%20an%20ongoing%20randomized%20trial%20to%20assess%20continuous%20quality%20improvement%20interventions%20%28CQI%29%20for%20prevention%20of%20mother-to-child%20transmission%20%28PMTCT%29%20of%20HIV%20%28CQI-PMTCT%20study%2C%20NCT03048669%29.%20HIV-infected%20women%20in%20the%20CQI-PMTCT%20cohort%20were%20tested%20for%20HCV%2C%20and%20risk%20factors%20were%20evaluated%20using%20logistic%20regression.%20The%20prevalence%20of%20HCV%5C%2FHIV%20co-infection%20among%20Congolese%20women%20was%200.83%25%20%2895%25%20CI%200.43-1.23%29.%20Women%20who%20tested%20positive%20for%20HCV%20were%20younger%2C%20more%20likely%20to%20live%20in%20urban%20areas%2C%20and%20more%20likely%20to%20test%20positive%20during%20pregnancy%20versus%20postpartum.%20HCV-positive%20women%20had%20significantly%20higher%20odds%20of%20infection%20with%20hepatitis%20B%20virus%20%28HBV%29%20%28aOR%2013.87%20%5B3.29%2C58.6%5D%29.%20An%20inverse%20relationship%20was%20noted%20between%20HCV%20infection%20and%20the%20overall%20capacity%20of%20the%20health%20facility%20as%20measured%20by%20the%20service%20readiness%20index%20%28SRI%29%20%28aOR%3A0.92%20%5B0.86%2C0.98%5D%20per%20unit%20increase%29.%20Women%20who%20presented%20to%20rural%2C%20for-profit%20and%20PEPFAR-funded%20health%20facilities%20were%20more%20likely%20to%20test%20positive%20for%20HCV.%20In%20summary%2C%20this%20study%20identified%20that%20the%20prevalence%20of%20HCV%5C%2FHIV%20co-infection%20was%20%3C%201%25%20among%20Congolese%20women.%20We%20also%20identified%20HBV%20infection%20as%20a%20major%20risk%20factor%20for%20HCV%5C%2FHIV%20co-infection.%20Individuals%20with%20triple%20infection%20should%20be%20linked%20to%20care%20and%20the%20facility-related%20differences%20in%20HCV%20prevalence%20should%20be%20addressed%20in%20future%20studies.%22%2C%22date%22%3A%22Jan%2026%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-022-05014-3%22%2C%22ISSN%22%3A%222045-2322%20%28Electronic%29%202045-2322%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22ZBJI578D%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A46%3A02Z%22%7D%7D%2C%7B%22key%22%3A%22YUUBPBD9%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Romo%20et%20al.%22%2C%22parsedDate%22%3A%222022-01%22%2C%22numChildren%22%3A12%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERomo%2C%20M.%20L.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EPatel%2C%20R.%20C.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEdwards%2C%20J.%20K.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EHumphrey%2C%20J.%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMusick%2C%20B.%20S.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Disparities%20in%20Dolutegravir%20Uptake%20Affecting%20Females%20of%20Reproductive%20Age%20With%20HIV%20in%20Low-%20and%20Middle-Income%20Countries%20After%20Initial%20Concerns%20About%20Teratogenicity%26%23x202F%3B%3A%20An%20Observational%20Study.%20%3Ci%3EAnn%20Intern%20Med%3C%5C%2Fi%3E%2C%20%3Ci%3E175%3C%5C%2Fi%3E%20%281%29%2C%20S.%2084%26%23x2013%3B94.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7326%5C%2FM21-3037%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.7326%5C%2FM21-3037%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Disparities%20in%20Dolutegravir%20Uptake%20Affecting%20Females%20of%20Reproductive%20Age%20With%20HIV%20in%20Low-%20and%20Middle-Income%20Countries%20After%20Initial%20Concerns%20About%20Teratogenicity%20%3A%20An%20Observational%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20L.%22%2C%22lastName%22%3A%22Romo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20C.%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20K.%22%2C%22lastName%22%3A%22Edwards%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20M.%22%2C%22lastName%22%3A%22Humphrey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20S.%22%2C%22lastName%22%3A%22Musick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20W.%22%2C%22lastName%22%3A%22Maina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Castelnuovo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Penner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Wyka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20W.%22%2C%22lastName%22%3A%22Cardoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20S.%22%2C%22lastName%22%3A%22Ly%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Kunzekwenyika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Panczak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20A.%22%2C%22lastName%22%3A%22Kelvin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20K.%22%2C%22lastName%22%3A%22Wools-Kaloustian%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aids%22%2C%22lastName%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20transition%20to%20dolutegravir-containing%20antiretroviral%20therapy%20%28ART%29%20in%20low-%20and%20middle-income%20countries%20%28LMICs%29%20was%20complicated%20by%20an%20initial%20safety%20signal%20in%20May%202018%20suggesting%20that%20exposure%20to%20dolutegravir%20at%20conception%20was%20possibly%20associated%20with%20infant%20neural%20tube%20defects.%20On%20the%20basis%20of%20additional%20evidence%2C%20in%20July%202019%2C%20the%20World%20Health%20Organization%20recommended%20dolutegravir%20for%20all%20adults%20and%20adolescents%20living%20with%20HIV.%20OBJECTIVE%3A%20To%20describe%20dolutegravir%20uptake%20and%20disparities%20by%20sex%20and%20age%20group%20in%20LMICs.%20DESIGN%3A%20Observational%20cohort%20study.%20SETTING%3A%2087%20sites%20that%20began%20using%20dolutegravir%20in%2011%20LMICs%20in%20the%20Asia-Pacific%3B%20Caribbean%2C%20Central%20and%20South%20America%20network%20for%20HIV%20epidemiology%20%28CCASAnet%29%3B%20and%20sub-Saharan%20African%20regions%20of%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28IeDEA%29%20consortium.%20PATIENTS%3A%20134%20672%20patients%20aged%2016%20years%20or%20older%20who%20received%20HIV%20care%20from%20January%202017%20through%20March%202020.%20MEASUREMENTS%3A%20Sex%2C%20age%20group%2C%20and%20dolutegravir%20uptake%20%28that%20is%2C%20newly%20initiating%20ART%20with%20dolutegravir%20or%20switching%20to%20dolutegravir%20from%20another%20regimen%29.%20RESULTS%3A%20Differences%20in%20dolutegravir%20uptake%20among%20females%20of%20reproductive%20age%20%2816%20to%2049%20years%29%20emerged%20after%20the%20safety%20signal.%20By%20the%20end%20of%20follow-up%2C%20the%20cumulative%20incidence%20of%20dolutegravir%20uptake%20among%20females%2016%20to%2049%20years%20old%20was%2029.4%25%20%2895%25%20CI%2C%2029.0%25%20to%2029.7%25%29%20compared%20with%2057.7%25%20%28CI%2C%2057.2%25%20to%2058.3%25%29%20among%20males%2016%20to%2049%20years%20old.%20This%20disparity%20was%20greater%20in%20countries%20that%20began%20implementing%20dolutegravir%20before%20the%20safety%20signal%20and%20initially%20had%20highly%20restrictive%20policies%20versus%20countries%20with%20a%20later%20rollout.%20Dolutegravir%20uptake%20was%20similar%20among%20females%20and%20males%20aged%2050%20years%20or%20older.%20LIMITATION%3A%20Follow-up%20was%20limited%20to%206%20to%208%20months%20after%20international%20guidelines%20recommended%20expanding%20access%20to%20dolutegravir.%20CONCLUSION%3A%20Substantial%20disparities%20in%20dolutegravir%20uptake%20affecting%20females%20of%20reproductive%20age%20through%20early%202020%20are%20documented.%20Although%20this%20disparity%20was%20anticipated%20because%20of%20country-level%20restrictions%20on%20access%2C%20the%20results%20highlight%20its%20extent%20and%20initial%20persistence.%20PRIMARY%20FUNDING%20SOURCE%3A%20National%20Institutes%20of%20Health.%22%2C%22date%22%3A%22Jan%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.7326%5C%2FM21-3037%22%2C%22ISSN%22%3A%221539-3704%20%28Electronic%29%200003-4819%20%28Print%29%200003-4819%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A18%3A43Z%22%7D%7D%2C%7B%22key%22%3A%22DDDJFNDE%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rogers%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ERogers%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBrazier%2C%20E.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EDzudie%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EAdedimeji%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EYotebieng%2C%20M.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20COVID-19%20associated%20changes%20in%20HIV%20service%20delivery%20over%20time%20in%20Central%20Africa%3A%20Results%20from%20facility%20surveys%20during%20the%20first%20and%20second%20waves%20of%20the%20pandemic.%20%3Ci%3EPLoS%20One%3C%5C%2Fi%3E%2C%20%3Ci%3E17%3C%5C%2Fi%3E%20%2811%29%2C%20S.%20e0275429.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0275429%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0275429%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22COVID-19%20associated%20changes%20in%20HIV%20service%20delivery%20over%20time%20in%20Central%20Africa%3A%20Results%20from%20facility%20surveys%20during%20the%20first%20and%20second%20waves%20of%20the%20pandemic%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Rogers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Dzudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Adedimeji%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Muhoza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Twizere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nsonde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Mafoua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Munyaneza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Gateretse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Diafouka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Murenzi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Niyongabo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20The%20COVID-19%20pandemic%20has%20impacted%20population%20health%20around%20the%20globe%2C%20directly%20and%20indirectly.%20The%20objective%20of%20this%20study%20was%20to%20document%20changes%20in%20HIV%20care%20associated%20with%20the%20COVID-19%20pandemic%20at%20selected%20clinics%20in%20Central%20Africa%2C%20along%20with%20clinic-level%20strategies%20for%20minimizing%20disruptions%20in%20HIV%20care%20and%20treatment%20for%20people%20with%20HIV%20%28PWH%29.%20METHODS%3A%20A%2051-item%20questionnaire%20on%20COVID-19%20pandemic-associated%20changes%20in%20HIV%20service%20delivery%20was%20completed%20by%20clinicians%20involved%20in%20HIV%20care%20at%2021%20clinics%20in%20five%20countries%20participating%20in%20Central%20Africa%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20%28CA-IeDEA%29.%20The%20survey%20was%20completed%20at%20two%20timepoints%3A%20June-July%202020%20and%20October%202020%20to%20February%202021.%20Descriptive%20statistics%20were%20used%20to%20characterize%20changes%20in%20HIV%20care%20and%20related%20services.%20RESULTS%3A%20While%2081%25%20of%20sites%20reported%20at%20least%20one%20negative%20consequence%20of%20COVID-19%20for%20clinic%20operations%20during%20the%20first%20survey%2C%20none%20reported%20suspending%20antiretroviral%20therapy%20%28ART%29%20initiation%20services%20for%20new%20patients%2C%20and%2024%25%20reported%20adopting%20telemedicine.%20In%20the%20follow-up%20survey%2C%20fewer%20sites%20%2848%25%29%20reported%20at%20least%20one%20disruption%20to%20clinic%20operations%2C%20and%20more%20sites%20reported%20mitigation%20strategies%2C%20including%20expanding%20rapid%20ART%20initiation%20services%20and%20providing%20extra%20supplies%20of%20ART%20medications%20to%20reduce%20visit%20frequency.%20In%20the%20follow-up%20survey%2C%20more%20sites%2C%20especially%20in%20Rwanda%2C%20reported%20stockouts%20of%20commodities%2C%20including%20HIV%20and%20viral%20load%20testing%20and%20HIV%20pre-exposure%20prophylaxis.%20More%20than%20one-fifth%20of%20sites%20reported%20stockouts%20of%20second-%20or%20third-line%20ART%20at%20each%20survey%20timepoint.%20CONCLUSIONS%3A%20While%20the%20initial%20wave%20of%20the%20COVID-19%20pandemic%20resulted%20in%20concerning%20disruptions%20to%20HIV%20service%20delivery%20at%20CA-IeDEA%20sites%2C%20most%20of%20these%20disruptions%20attenuated%20over%20time%2C%20and%20many%20sites%20introduced%20measures%20to%20help%20PWH%20avoid%20frequent%20visits%20to%20the%20clinic%20for%20care%20and%20medications.%20The%20impact%20of%20HIV%20commodity%20stockouts%20and%20clinic%20mitigation%20strategies%20on%20treatment%20outcomes%20needs%20to%20be%20assessed.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0275429%22%2C%22ISSN%22%3A%221932-6203%20%28Electronic%29%201932-6203%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A40%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22GFLTERYK%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parcesepe%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EParcesepe%2C%20A.%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EFiliatreau%2C%20L.%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEbasone%2C%20P.%20V.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EDzudie%2C%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EPence%2C%20B.%20W.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Psychiatric%20comorbidity%20and%20psychosocial%20stressors%20among%20people%20initiating%20HIV%20care%20in%20Cameroon.%20%3Ci%3EPLoS%20One%3C%5C%2Fi%3E%2C%20%3Ci%3E17%3C%5C%2Fi%3E%20%286%29%2C%20S.%20e0270042.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0270042%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pone.0270042%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Psychiatric%20comorbidity%20and%20psychosocial%20stressors%20among%20people%20initiating%20HIV%20care%20in%20Cameroon%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%20M.%22%2C%22lastName%22%3A%22Parcesepe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20M.%22%2C%22lastName%22%3A%22Filiatreau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20V.%22%2C%22lastName%22%3A%22Ebasone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Dzudie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%20W.%22%2C%22lastName%22%3A%22Pence%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Wainberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Anastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Pefura-Yone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nsame%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Ajeh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Nash%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Psychiatric%20comorbidity%2C%20the%20presence%20of%20two%20or%20more%20mental%20health%20disorders%2C%20has%20been%20associated%20with%20suboptimal%20HIV%20treatment%20outcomes.%20Little%20is%20known%20about%20the%20prevalence%20of%20psychiatric%20comorbidity%20among%20people%20with%20HIV%20%28PWH%29%20in%20sub-Saharan%20Africa.%20METHODS%3A%20We%20conducted%20interviews%20with%20PWH%20initiating%20HIV%20care%20in%20Cameroon%20between%20June%202019%20and%20March%202020.%20Depression%2C%20anxiety%2C%20post-traumatic%20stress%20disorder%20%28PTSD%29%2C%20and%20harmful%20drinking%20were%20dichotomized%20to%20represent%20those%20with%20and%20without%20symptoms%20of%20each.%20Psychiatric%20comorbidity%20was%20defined%20as%20having%20symptoms%20of%20two%20or%20more%20disorders%20assessed.%20Moderate%20or%20severe%20household%20hunger%2C%20high%20anticipatory%20HIV-related%20stigma%2C%20low%20social%20support%2C%20and%20high%20number%20of%20potentially%20traumatic%20events%20were%20hypothesized%20as%20correlates%20of%20psychiatric%20comorbidity.%20Bivariable%20log%20binomial%20regression%20models%20were%20used%20to%20estimate%20unadjusted%20associations%20between%20psychosocial%20stressors%20and%20psychiatric%20comorbidity.%20RESULTS%3A%20Among%20424%20participants%20interviewed%2C%20the%20prevalence%20of%20psychiatric%20comorbidity%20was%2016%25.%20Among%20those%20with%20symptoms%20of%20at%20least%20one%20mental%20health%20or%20substance%20use%20disorder%20%28n%20%3D%20161%29%2C%20the%20prevalence%20of%20psychiatric%20comorbidity%20was%2042%25.%20The%20prevalence%20of%20psychiatric%20comorbidity%20was%2033%25%2C%2067%25%2C%2076%25%2C%20and%2081%25%20among%20those%20with%20symptoms%20of%20harmful%20drinking%2C%20depression%2C%20anxiety%2C%20and%20PTSD%2C%20respectively.%20Among%20individuals%20with%20symptoms%20of%20a%20mental%20health%20or%20substance%20use%20disorder%2C%20a%20high%20number%20of%20potentially%20traumatic%20events%20%28prevalence%20ratio%20%28PR%29%201.71%20%5B95%25%20CI%201.21%2C%202.42%5D%29%20and%20high%20anticipatory%20HIV-related%20stigma%20%28PR%201.45%20%5B95%25%20CI%201.01%2C%202.09%5D%29%20were%20associated%20with%20greater%20prevalence%20of%20psychiatric%20comorbidity.%20CONCLUSION%3A%20Psychiatric%20comorbidity%20was%20common%20among%20this%20group%20of%20PWH%20in%20Cameroon.%20The%20effectiveness%20and%20implementation%20of%20transdiagnostic%20or%20multi-focus%20mental%20health%20treatment%20approaches%20in%20HIV%20care%20settings%20should%20be%20examined.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pone.0270042%22%2C%22ISSN%22%3A%221932-6203%20%28Electronic%29%201932-6203%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22ZBJI578D%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A24%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22AMM6W376%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zurcher%20et%20al.%22%2C%22parsedDate%22%3A%222022%22%2C%22numChildren%22%3A16%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3E%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EZurcher%2C%20K.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3ECox%2C%20S.%20R.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EBallif%2C%20M.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EEnane%2C%20L.%20A.%3C%5C%2Fspan%3E%3B%20%3Cspan%20style%3D%5C%22text-decoration%3Anone%3B%5C%22%3EMarcy%2C%20O.%3C%5C%2Fspan%3E%20et%20al.%3C%5C%2Fspan%3E%20%282022%29.%20Integrating%20services%20for%20HIV%20and%20multidrug-resistant%20tuberculosis%3A%20A%20global%20cross-sectional%20survey%20among%20ART%20clinics%20in%20low-%20and%20middle-income%20countries.%20%3Ci%3EPLOS%20Glob%20Public%20Health%3C%5C%2Fi%3E%2C%20%3Ci%3E2%3C%5C%2Fi%3E%20%283%29%2C%20S.%20e0000180.%20%3Ca%20href%3D%27http%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0000180%27%3Ehttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1371%5C%2Fjournal.pgph.0000180%3C%5C%2Fa%3E.%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Integrating%20services%20for%20HIV%20and%20multidrug-resistant%20tuberculosis%3A%20A%20global%20cross-sectional%20survey%20among%20ART%20clinics%20in%20low-%20and%20middle-income%20countries%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%22%2C%22lastName%22%3A%22Zurcher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20R.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Marcy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Reubenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Imsanguan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Otero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Suryavanshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Egger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20A.%22%2C%22lastName%22%3A%22Tornheim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aids%22%2C%22lastName%22%3A%22International%20Epidemiology%20Databases%20to%20Evaluate%22%7D%5D%2C%22abstractNote%22%3A%22Tuberculosis%20%28TB%29%20is%20the%20leading%20cause%20of%20death%20among%20PLHIV%20and%20multidrug-resistant-TB%20%28MDR-TB%29%20is%20associated%20with%20high%20mortality.%20We%20examined%20the%20management%20for%20adult%20PLHIV%20coinfected%20with%20MDR-TB%20at%20ART%20clinics%20in%20lower%20income%20countries.%20Between%202019%20and%202020%2C%20we%20conducted%20a%20cross-sectional%20survey%20at%2029%20ART%20clinics%20in%20high%20TB%20burden%20countries%20within%20the%20global%20IeDEA%20network.%20We%20used%20structured%20questionnaires%20to%20collect%20clinic-level%20data%20on%20the%20TB%20and%20HIV%20services%20and%20the%20availability%20of%20diagnostic%20tools%20and%20treatment%20for%20MDR-TB.%20Of%2029%20ART%20clinics%2C%2025%20%2886%25%29%20were%20in%20urban%20areas%20and%2019%20%2866%25%29%20were%20tertiary%20care%20clinics.%20Integrated%20HIV-TB%20services%20were%20reported%20at%2025%20%2886%25%29%20ART%20clinics%20for%20pan-susceptible%20TB%2C%20and%2014%20%2848%25%29%20clinics%20reported%20full%20MDR-TB%20services%20on-site%2C%20i.e.%20drug%20susceptibility%20testing%20%5BDST%5D%20and%20MDR-TB%20treatment.%20Some%20form%20of%20DST%20was%20available%20on-site%20at%2022%20%2876%25%29%20clinics%2C%20while%20the%20remainder%20referred%20testing%20off-site.%20On-site%20DST%20for%20second-line%20drugs%20was%20available%20at%209%20%2831%25%29%20clinics.%20MDR-TB%20treatment%20was%20delivered%20on-site%20at%2015%20%2852%25%29%20clinics%2C%20with%2010%20individualizing%20treatment%20based%20on%20DST%20results%20and%20five%20using%20standardized%20regimens%20alone.%20Bedaquiline%20was%20routinely%20available%20at%205%20%2817%25%29%20clinics%20and%20delamanid%20at%203%20%2810%25%29%20clinics.%20Although%20most%20ART%20clinics%20reported%20having%20integrated%20HIV%20and%20TB%20services%2C%20few%20had%20fully%20integrated%20MDR-TB%20services.%20There%20is%20a%20continued%20need%20for%20increased%20access%20to%20diagnostic%20and%20treatment%20options%20for%20MDR-TB%20patients%20and%20better%20integration%20of%20MDR-TB%20services%20into%20the%20HIV%20care%20continuum.%22%2C%22date%22%3A%222022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1371%5C%2Fjournal.pgph.0000180%22%2C%22ISSN%22%3A%222767-3375%20%28Electronic%29%202767-3375%20%28Linking%29%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22GXCKG69T%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%5D%2C%22dateModified%22%3A%222023-08-20T14%3A36%3A43Z%22%7D%7D%5D%7D
Brazier, E.; Ajeh, R.; Maruri, F.; Musick, B.; Freeman, A. et al. (2022). Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium.
J Int AIDS Soc,
25 (12), S. e26036.
http://doi.org/10.1002/jia2.26036.
Wada, P. Y.; Kim, A.; Jayathilake, K.; Duda, S. N.; Abo, Y. et al. (2022). Site-Level Comprehensiveness of Care Is Associated with Individual Clinical Retention Among Adults Living with HIV in International Epidemiology Databases to Evaluate AIDS, a Global HIV Cohort Collaboration, 2000-2016.
AIDS Patient Care STDS,
36 (9), S. 343–355.
http://doi.org/10.1089/apc.2022.0042.
Edmonds, A.; Brazier, E.; Musick, B. S.; Yotebieng, M.; Humphrey, J. et al. (2022). Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study.
PLoS Med,
19 (9), S. e1004089.
http://doi.org/10.1371/journal.pmed.1004089.
Murenzi, G.; Shumbusho, F.; Hansen, N.; Munyaneza, A.; Gage, J. C. et al. (2022). Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol.
BMJ Open,
12 (8), S. e061650.
http://doi.org/10.1136/bmjopen-2022-061650.
Filiatreau, L. M.; Ebasone, P. V.; Dzudie, A.; Ajeh, R.; Pence, B. W. et al. (2022). Prevalence of stressful life events and associations with symptoms of depression, anxiety, and post-traumatic stress disorder among people entering care for HIV in Cameroon.
J Affect Disord,
308, S. 421–431.
http://doi.org/10.1016/j.jad.2022.04.061.
Romo, M. L.; Brazier, E.; Mahambou-Nsonde, D.; De Waal, R.; Sekaggya-Wiltshire, C. et al. (2022). Real-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa.
J Int AIDS Soc,
25 (7), S. e25961.
http://doi.org/10.1002/jia2.25961.
Lewis, J. T.; Stephens, J.; Musick, B.; Brown, S.; Malateste, K. et al. (2022). The IeDEA harmonist data toolkit: A data quality and data sharing solution for a global HIV research consortium.
J Biomed Inform,
131, S. 104110.
http://doi.org/10.1016/j.jbi.2022.104110.
Lewis, J. T.;
Brazier, E.;
Katz, B.;
Nash, D. &
Duda, S. N. (2022). A Method for Generating Dashboard Aggregations in an International HIV Consortium.
Stud Health Technol Inform,
290, S. 1048–1049.
http://doi.org/10.3233/SHTI220261.
Antimycobacterial Susceptibility Testing, Group (2022). Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.
Eur Respir J,
59 (4), S. 2200166.
http://doi.org/10.1183/13993003.00166-2022.
Justice, A. C.; Goetz, M. B.; Stewart, C. N.; Hogan, B. C.; Humes, E. et al. (2022). Delayed presentation of HIV among older individuals: a growing problem.
Lancet HIV,
9 (4), S. e269–e280.
http://doi.org/10.1016/S2352-3018(22)00003-0.
Parcesepe, A. M.; Remch, M.; Dzudie, A.; Ajeh, R.; Nash, D. et al. (2022). Depressive Symptoms, Gender, Disclosure, and HIV Care Stage Among People Living with HIV in Cameroon.
AIDS Behav,
26 (3), S. 651–661.
http://doi.org/10.1007/s10461-021-03425-3.
Collaborative Initiative for Paediatric, H. I. V. Education; Research Global Cohort, Collaboration; Jesson, J.; Crichton, S.; Quartagno, M. et al. (2022). Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis.
J Int AIDS Soc,
25 (3), S. e25871.
http://doi.org/10.1002/jia2.25871.
Shaikh, K.; Bhondoekhan, F.; Haberlen, S.; Nakanishi, R.; Roy, S. K. et al. (2022). Coronary artery plaque progression and cardiovascular risk scores in men with and without HIV-infection.
AIDS,
36 (2), S. 215–224.
http://doi.org/10.1097/QAD.0000000000003093.
Zotova, N.; Familiar, I.; Kawende, B.; Kasindi, F. L.; Ravelomanana, N. et al. (2022). HIV disclosure and depressive symptoms among pregnant women living with HIV: a cross-sectional study in the Democratic Republic of Congo.
J Int AIDS Soc,
25 (2), S. e25865.
http://doi.org/10.1002/jia2.25865.
Sam-Agudu, N. A.;
Quakyi, N. K.;
Masekela, R.;
Zumla, A. &
Nachega, J. B. (2022). Children and adolescents in African countries should also be vaccinated for COVID-19.
BMJ Glob Health,
7 (2), S. e008315.
http://doi.org/10.1136/bmjgh-2021-008315.
Thompson, P.; Mpody, C.; Sayre, W.; Rigney, C.; Tabala, M. et al. (2022). Hepatitis C prevalence and quality of health services among HIV-positive mothers in the Democratic Republic of the Congo.
Sci Rep,
12 (1), S. 1384.
http://doi.org/10.1038/s41598-022-05014-3.
Romo, M. L.; Patel, R. C.; Edwards, J. K.; Humphrey, J. M.; Musick, B. S. et al. (2022). Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study.
Ann Intern Med,
175 (1), S. 84–94.
http://doi.org/10.7326/M21-3037.
Rogers, A.; Brazier, E.; Dzudie, A.; Adedimeji, A.; Yotebieng, M. et al. (2022). COVID-19 associated changes in HIV service delivery over time in Central Africa: Results from facility surveys during the first and second waves of the pandemic.
PLoS One,
17 (11), S. e0275429.
http://doi.org/10.1371/journal.pone.0275429.
Parcesepe, A. M.; Filiatreau, L. M.; Ebasone, P. V.; Dzudie, A.; Pence, B. W. et al. (2022). Psychiatric comorbidity and psychosocial stressors among people initiating HIV care in Cameroon.
PLoS One,
17 (6), S. e0270042.
http://doi.org/10.1371/journal.pone.0270042.
Zurcher, K.; Cox, S. R.; Ballif, M.; Enane, L. A.; Marcy, O. et al. (2022). Integrating services for HIV and multidrug-resistant tuberculosis: A global cross-sectional survey among ART clinics in low- and middle-income countries.
PLOS Glob Public Health,
2 (3), S. e0000180.
http://doi.org/10.1371/journal.pgph.0000180.
2021
Agler, Robert A.; Zivich, Paul N.; Kawende, Bienvenu; Behets, Frieda & Yotebieng, Marcel (2021). Postpartum depressive symptoms following implementation of the 10 steps to successful breastfeeding program in Kinshasa, Democratic Republic of Congo: A cohort study. PLOS Medicine, 18 (1), S. e1003465–e1003465. http://doi.org/10.1371/journal.pmed.1003465.
Pierz, Amanda J.; Ajeh, Rogers; Fuhngwa, Norbert; Nasah, Judith; Dzudie, Anastase et al. (2021). Acceptability of Self-Sampling for Cervical Cancer Screening Among Women Living With HIV and HIV-Negative Women in Limbé, Cameroon. Frontiers in Reproductive Health, 2, S. 561202–561202. http://doi.org/10.3389/frph.2020.561202.
Tsondai, Priscilla Ruvimbo; Davies, Mary-Ann; Singtoroj, Thida; Maxwell, Nicola; McGowan, Catherine C. et al. (2021). Improving Methods to Classify Perinatal versus Nonperinatal HIV Acquisition in Young Adolescents 10-14 Years of Age. The Pediatric Infectious Disease Journal. http://doi.org/10.1097/INF.0000000000003059.
Mageras, Anna; Brazier, Ellen; Niyongabo, Théodore; Murenzi, Gad; D’Amour Sinayobye, Jean et al. (2021). Comparison of cohort characteristics in Central Africa International Epidemiology Databases to Evaluate AIDS and Demographic Health Surveys: Rwanda and Burundi. International Journal of STD & AIDS, S. 956462420983783. http://doi.org/10.1177/0956462420983783.
Adedimeji, Adebola; Ajeh, Rogers; Pierz, Amanda; Nkeng, Relindis; Ndenkeh, Jackson Jr et al. (2021). Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context. BMC Women’s Health, 21 (1), S. 74. http://doi.org/10.1186/s12905-021-01211-w.
Chiarappa, Joseph A. & Hoover, Donald R. (2021). Comparative poisson clinical trials of multiple experimental treatments vs a single control using the negative multinomial distribution. Statistics in Medicine. http://doi.org/10.1002/sim.8914.
Brazier, Ellen; Tymejczyk, Olga; Zaniewski, Elizabeth; Egger, Matthias; Wools-Kaloustian, Kara et al. (2021). Effects of national adoption of Treat-All guidelines on pre-ART CD4 testing and viral load monitoring after ART initiation: A regression discontinuity analysis. Clinical Infectious Diseases, S. ciab222. http://doi.org/10.1093/cid/ciab222.
McMahon, Devon E.; Semeere, Aggrey; Laker-Oketta, Miriam; Byakwaga, Helen; Mugglin, Catrina et al. (2021). Global disparities in skin cancer services at HIV treatment centers across 29 countries. The Journal of Investigative Dermatology. http://doi.org/10.1016/j.jid.2021.02.758.
Ross, Jonathan; Murenzi, Gad; Hill, Sarah; Remera, Eric; Ingabire, Charles et al. (2021). Reducing time to differentiated service delivery for newly diagnosed people living with HIV in Kigali, Rwanda: study protocol for a pilot, unblinded, randomised controlled study. BMJ Open, 11 (4), S. e047443. http://doi.org/10.1136/bmjopen-2020-047443.
Iyun, Victoria; Technau, Karl-Gunter; Vinikoor, Michael; Yotebieng, Marcel; Vreeman, Rachel et al. (2021). Variations in the characteristics and outcomes of children living with HIV following universal ART in sub-Saharan Africa (2006-17): a retrospective cohort study. The Lancet. HIV. http://doi.org/10.1016/S2352-3018(21)00004-7.
Yumo, Habakkuk A.; Ndenkeh, Jackson N.; Sieleunou, Isidore; Nsame, Denis N.; Kuwoh, Pius B. et al. (2021). Human immunodeficiency virus case detection and antiretroviral therapy enrollment among children below and above 18 months old: A comparative analysis from Cameroon. Medicine, 100 (17), S. e25510. http://doi.org/10.1097/MD.0000000000025510.
Fouda, Genevieve G. A.; Kwiek, Jesse J. & Yotebieng, Marcel (2021). Safety of Breastfeeding by Mothers With COVID-19: New Evidence From Israel. Pediatrics, 147 (5). http://doi.org/10.1542/peds.2020-049772.
Filiatreau, Lindsey M.; Ebasone, Peter Vanes; Dzudie, Anastase; Ajeh, Rogers; Pence, Brian et al. (2021). Correlates of self-reported history of mental health help-seeking: a cross-sectional study among individuals with symptoms of a mental or substance use disorder initiating care for HIV in Cameroon. BMC Psychiatry, 21 (1), S. 293. http://doi.org/10.1186/s12888-021-03306-y.
Parcesepe, Angela M.; Filiatreau, Lindsey M.; Ebasone, Peter Vanes; Dzudie, Anastase; Ajeh, Rogers et al. (2021). Gender, Mental Health, and Entry Into Care with Advanced HIV Among People Living with HIV in Cameroon Under a National “Treat All” Policy. AIDS and Behavior. http://doi.org/10.1007/s10461-021-03328-3.
Adedimeji, Adebola A.; Hoover, Donald R.; Shi, Qiuhu; Kim, Hae-Young; Brazier, Ellen et al. (2021). Trends in demographic and clinical characteristics and initiation of antiretroviral therapy among adult patients enrolling in HIV care in the Central Africa International epidemiology Database to Evaluate AIDS (CA-IeDEA) 2004 to 2018. Journal of the International AIDS Society, 24 (6), S. e25672. http://doi.org/10.1002/jia2.25672.
Parcesepe, Angela M.; Remch, Molly; Dzudie, Anastase; Ajeh, Rogers; Nash, Denis et al. (2021). Depressive Symptoms, Gender, Disclosure, and HIV Care Stage Among People Living with HIV in Cameroon. AIDS and Behavior. http://doi.org/10.1007/s10461-021-03425-3.
Johnson, Leigh F.; Kariminia, Azar; Trickey, Adam; Yiannoutsos, Constantin T.; Ekouevi, Didier K. et al. (2021). Achieving consistency in measures of HIV-1 viral suppression across countries: derivation of an adjustment based on international antiretroviral treatment cohort data. Journal of the International AIDS Society, 24 Suppl 5, S. e25776. http://doi.org/10.1002/jia2.25776.
Irvine, Mary K.; Robertson, McKaylee M.; Nash, Denis; Kulkarni, Sarah G.; Braunstein, Sarah L. et al. (2021). HIV Care Coordination promotes care re-engagement and viral suppression among people who have been out of HIV medical care: an observational effectiveness study using a surveillance-based contemporaneous comparison group. AIDS Research and Therapy, 18 (1), S. 70. http://doi.org/10.1186/s12981-021-00398-0.
Parcesepe, Angela M.; Filiatreau, Lindsey M.; Ebasone, Peter Vanes; Dzudie, Anastase; Pence, Brian W. et al. (2021). Mental health and initiation of antiretroviral treatment at enrolment into HIV care in Cameroon under a national “treat all” policy: a cross-sectional analysis. Journal of the International AIDS Society, 24 (11), S. e25842. http://doi.org/10.1002/jia2.25842.
Filiatreau, Lindsey M.; Ebasone, Peter Vanes; Dzudie, Anastase; Ajeh, Rogers; Pence, Brian W. et al. (2021). Underestimation of potentially traumatic events resulting from underreporting of physical and sexual violence among people entering care for HIV in Cameroon. Psychological Trauma: Theory, Research, Practice and Policy. http://doi.org/10.1037/tra0001175.
Lancaster, Kathryn E.; Remch, Molly; Dzudie, Anastase; Ajeh, Rogers; Adedimeji, Adebola et al. (2021). Heavy episodic drinking and HIV disclosure by HIV treatment status among People with HIV in IeDEA Cameroon. The International Journal on Drug Policy, 98, S. 103431. http://doi.org/10.1016/j.drugpo.2021.103431.
Dzudie, Anastase; Hoover, Donald; Kim, Hae-Young; Ajeh, Rogers; Adedimeji, Adebola et al. (2021). Hypertension among people living with HIV/AIDS in Cameroon: A cross-sectional analysis from Central Africa International Epidemiology Databases to Evaluate AIDS. PloS One, 16 (7), S. e0253742. http://doi.org/10.1371/journal.pone.0253742.
Han, Win Min; Law, Matthew G.; Egger, Matthias; Wools-Kaloustian, Kara; Moore, Richard et al. (2021). Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries. The Lancet HIV, 8 (12), S. e766–e775. http://doi.org/10.1016/S2352-3018(21)00265-4.
Kassanjee, Reshma; Johnson, Leigh F.; Zaniewski, Elizabeth; Ballif, Marie; Christ, Benedikt et al. (2021). Global HIV mortality trends among children on antiretroviral treatment corrected for under‐reported deaths: an updated analysis of the International epidemiology Databases to Evaluate AIDS collaboration. Journal of the International AIDS Society, 24 (S5). http://doi.org/10.1002/jia2.25780.
Ross, Jonathan; Ingabire, Charles; Umwiza, Francine; Gasana, Josephine; Munyaneza, Athanase et al. (2021). How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda-A qualitative study. PloS One, 16 (5), S. e0251645. http://doi.org/10.1371/journal.pone.0251645.
Zürcher, Kathrin; Reichmuth, Martina L.; Ballif, Marie; Loiseau, Chloé; Borrell, Sonia et al. (2021). Mortality from drug-resistant tuberculosis in high-burden countries comparing routine drug susceptibility testing with whole-genome sequencing: a multicentre cohort study. The Lancet Microbe, 2 (7), S. e320–e330. http://doi.org/10.1016/S2666-5247(21)00044-6.
2020
Humphrey, John M.; Mpofu, Philani; Pettit, April C.; Musick, Beverly; Carter, E. Jane et al. (2020). Mortality Among People With HIV Treated for Tuberculosis Based on Positive, Negative, or No Bacteriologic Test Results for Tuberculosis: The IeDEA Consortium. Open Forum Infectious Diseases, 7 (1), S. ofaa006–ofaa006. http://doi.org/10.1093/ofid/ofaa006.
Patel, Kunjal; Smith, Colette; Collins, Intira Jeannie; Goodall, Ruth; Abrams, Elaine J. et al. (2020). Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis. Journal of the International AIDS Society, 23 (4). http://doi.org/10.1002/jia2.25477.
Yumo, Habakkuk A.; Ajeh, Rogers A.; Sieleunou, Isidore; Ndenkeh, Jackson N.; Jordan, Michael R. et al. (2020). Parental and child-level predictors of HIV testing uptake, seropositivity and treatment initiation among children and adolescents in Cameroon. PLoS ONE, 15 (4). http://doi.org/10.1371/journal.pone.0230988.
Chammartin, Frédérique; Dao Ostinelli, Cam Ha; Anastos, Kathryn; Jaquet, Antoine; Brazier, Ellen et al. (2020). International epidemiology databases to evaluate AIDS (IeDEA) in sub-Saharan Africa, 2012-2019. BMJ Open, 10 (5). http://doi.org/10.1136/bmjopen-2019-035246.
Jesson, Julie; Desmonde, Sophie; Yiannoutsos, Constantin T.; Patten, Gabriela; Malateste, Karen et al. (2020). Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium. BMC Research Notes, 13 (1), S. 249–249. http://doi.org/10.1186/s13104-020-05081-7.
Ross, Jonathan; Ribakare, Muhayimpundu; Remera, Eric; Murenzi, Gad; Munyaneza, Athanase et al. (2020). High levels of viral load monitoring and viral suppression under Treat All in Rwanda – a cross‐sectional study. Journal of the International AIDS Society, 23 (6). http://doi.org/10.1002/jia2.25543.
Loiseau, Chloé; Brites, Daniela; Reinhard, Miriam; Zürcher, Kathrin; Borrell, Sonia et al. (2020). HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. http://doi.org/10.1128/AAC.00782-20.
Adedimeji, Adebola; Ajeh, Rogers; Dzudie, Anastase; Kendowo, Ernestine; Fuhngwa, Norbert et al. (2020). Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon. Journal of Clinical Virology, 128. http://doi.org/10.1016/j.jcv.2020.104445.
Chan, Andrew T.; Drew, David A.; Nguyen, Long H.; Joshi, Amit D.; Ma, Wenjie et al. (2020). The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action. Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 29 (7), S. 1283–1289. http://doi.org/10.1158/1055-9965.EPI-20-0606.
Parcesepe, Angela M.; Lancaster, Kathryn; Edelman, E. Jennifer; DeBoni, Raquel; Ross, Jeremy et al. (2020). Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017. PLoS ONE, 15 (8 August), S. e0237772–e0237772. http://doi.org/10.1371/journal.pone.0237772.
Desmonde, Sophie; Neilan, Anne M.; Musick, Beverly; Patten, Gabriela; Chokephaibulkit, Kulkanya et al. (2020). Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Gl. Journal of the International AIDS Society, 23 (10), S. e25617–e25617. http://doi.org/10.1002/jia2.25617.
Rebeiro, Peter F.; Duda, Stephany N.; Wools-Kaloustian, Kara K.; Nash, Denis & Althoff, Keri N. (2020). Implications of COVID-19 for HIV Research: data sources, indicators and longitudinal analyses. Journal of the International AIDS Society, 23 (10), S. e25627–e25627. http://doi.org/10.1002/jia2.25627.
Reichmuth, Martina L.; Hömke, Rico; Zürcher, Kathrin; Sander, Peter; Avihingsanon, Anchalee et al. (2020). Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients. Antimicrobial Agents and Chemotherapy, 64 (11). http://doi.org/10.1128/AAC.00513-20.
Castle, Philip E.; Ajeh, Rogers; Dzudie, Anastase; Kendowo, Ernestine; Fuhngwa, Norbert et al. (2020). A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon. Infectious Agents and Cancer, 15, S. 45. http://doi.org/10.1186/s13027-020-00311-w.
Edwards, Jessie K.; Lesko, Catherine R.; Herce, Michael E.; Murenzi, Gad; Twizere, Christella et al. (2020). Gone But Not Lost: Implications for Estimating HIV Care Outcomes When Loss to Clinic Is Not Loss to Care. Epidemiology, 31 (4), S. 570–577. http://doi.org/10.1097/EDE.0000000000001201.
2019
Adedimeji, Adebola; Sinayobye, Jean d’Amour; Asiimwe-Kateera, Brenda; Chaudhry, Junaid; Buzinge, Lydia et al. (2019). Social contexts as mediator of risk behaviors in Rwandan men who have sex with men (MSM): Implications for HIV and STI transmission. PLOS ONE, 14 (1), S. e0211099–e0211099. http://doi.org/10.1371/journal.pone.0211099.
Yotebieng, Marcel; Brazier, Ellen; Addison, Diane; Kimmel, April D.; Cornell, Morna et al. (2019). Research priorities to inform “Treat All” policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). Journal of the International AIDS Society, 22 (1), S. e25218–e25218. http://doi.org/10.1002/jia2.25218.
Gygli, Sebastian M.; Keller, Peter M.; Ballif, Marie; Blöchliger, Nicolas; Hömke, Rico et al. (2019). Whole-Genome Sequencing for Drug Resistance Profile Prediction in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 63 (4). http://doi.org/10.1128/AAC.02175-18.
Ross, Jonathan; Sinayobye, Jean d’Amour; Yotebieng, Marcel; Hoover, Donald R.; Shi, Qiuhu et al. (2019). Early outcomes after implementation of treat all in Rwanda: an interrupted time series study. Journal of the International AIDS Society, 22 (4), S. e25279–e25279. http://doi.org/10.1002/jia2.25279.
Cornejo Castro, Elena M.; Morrison, Brian J.; Marshall, Vickie A.; Labo, Nazzarena; Miley, Wendell J. et al. (2019). Relationship between human leukocyte antigen alleles and risk of Kaposi’s sarcoma in Cameroon. Genes and Immunity. http://doi.org/10.1038/s41435-019-0077-9.
Mpody, Christian; Thompson, Peyton; Tabala, Martine; Ravelomanana, Noro Lantoniaina Rosa; Malongo, Fathy et al. (2019). Hepatitis B infection among pregnant and post-partum women living with HIV and on antiretroviral therapy in Kinshasa, DR Congo: A cross-sectional study. PloS One, 14 (5), S. e0216293–e0216293. http://doi.org/10.1371/journal.pone.0216293.
Mpody, Christian; Reline, Travis; Ravelomanana, Noro Lantoniaina Rosa; Kawende, Bienvenu; Okitolonda, Emile W. et al. (2019). Breastfeeding Support Offered at Delivery is Associated with Higher Prevalence of Exclusive Breastfeeding at 6 Weeks Postpartum Among HIV Exposed Infants: A Cross-Sectional Analysis. Maternal and Child Health Journal. http://doi.org/10.1007/s10995-019-02760-1.
Brazier, Ellen; Maruri, Fernanda; Duda, Stephany N.; Tymejczyk, Olga; Wester, C. William et al. (2019). Implementation of “Treat-all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey. Journal of the International AIDS Society, 22 (7), S. e25331–e25331. http://doi.org/10.1002/jia2.25331.
Muhoza, Benjamin; Remera, Eric; Shi, Qiuhu; Kabahizi, Jules; Brazier, Ellen et al. (2019). Secondary Data Use in Rwanda: Leveraging OpenMRS for Global HIV Research. Studies in Health Technology and Informatics, 264, S. 1732–1732. http://doi.org/10.3233/SHTI190620.
Ngamani, Lionel; Ajeh, Rogers; Mbuh, Akindeh; Dzudie, Anastase & Duda, Stephany N. (2019). Implementation of a REDCap-Based Research Data Collection System in Cameroon. Studies in Health Technology and Informatics, 264, S. 1708–1709. http://doi.org/10.3233/SHTI190608.
Yotebieng, Marcel; Mpody, Christian; Ravelomanana, Noro Lr; Tabala, Martine; Malongo, Fathy et al. (2019). HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study. Journal of the International AIDS Society, 22 (9), S. e25376–e25376. http://doi.org/10.1002/jia2.25376.
Zürcher, Kathrin; Ballif, Marie; Kiertiburanakul, Sasisopin; Chenal, Henri; Yotebieng, Marcel et al. (2019). Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. Journal of the International AIDS Society, 22 (9), S. e25392–e25392. http://doi.org/10.1002/jia2.25392.
Jesson, Julie; Schomaker, Michael; Malasteste, Karen; Wati, Dewi K.; Kariminia, Azar et al. (2019). Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. Journal of the International AIDS Society, 22 (11), S. e25412–e25412. http://doi.org/10.1002/jia2.25412.
Tymejczyk, Olga; Brazier, Ellen; Wools-Kaloustian, Kara; Davies, Mary-Ann; DiLorenzo, Madeline et al. (2019). Impact of universal antiretroviral treatment eligibility on rapid treatment initiation among young adolescents with HIV in sub-Saharan Africa. The Journal of Infectious Diseases. http://doi.org/10.1093/infdis/jiz547.
Brault, Marie A.; Spiegelman, Donna; Hargreaves, James; Nash, Denis & Vermund, Sten H. (2019). Treatment as Prevention: Concepts and Challenges for Reducing HIV Incidence. Journal of Acquired Immune Deficiency Syndromes (1999), 82 Suppl 2, S. S104–S112. http://doi.org/10.1097/QAI.0000000000002168.
Johnson, Leigh F.; Anderegg, Nanina; Zaniewski, Elizabeth; Eaton, Jeffrey W.; Rebeiro, Peter F. et al. (2019). Global variations in mortality in adults after initiating antiretroviral treatment: an updated analysis of the International epidemiology Databases to Evaluate AIDS cohort collaboration. AIDS (London, England), 33 Suppl 3, S. S283–S294. http://doi.org/10.1097/QAD.0000000000002358.
Pettit, April C.; Jenkins, Cathy A.; Blevins Peratikos, Meridith; Yotebieng, Marcel; Diero, Lameck et al. (2019). Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries. Journal of the International AIDS Society, 22 (12), S. e25423–e25423. http://doi.org/10.1002/jia2.25423.
Stover, John; Glaubius, Robert; Mofenson, Lynne; Dugdale, Caitlin M.; Davies, Mary Ann et al. (2019). Updates to the Spectrum/AIM model for estimating key HIV indicators at national and subnational levels. AIDS, 33, S. S227–S234. http://doi.org/10.1097/QAD.0000000000002357.
2018
Desmonde, Sophie; Tanser, Franck; Vreeman, Rachel; Takassi, Elom; Edmonds, Andrew et al. (2018). Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study. PLoS Medicine, 15 (5), S. e1002565–e1002565. http://doi.org/10.1371/journal.pmed.1002565.
Arrivé, Elise; Ayaya, Samuel; Davies, Mary-Ann; Chimbetete, Cleophas; Edmonds, Andrew et al. (2018). Models of support for disclosure of HIV status to HIV-infected children and adolescents in resource-limited settings. Journal of the International AIDS Society, 21 (7), S. e25157–e25157. http://doi.org/10.1002/jia2.25157.
Yumo, Habakkuk Azinyui; Kuaban, Christopher; Ajeh, Rogers Awoh; Nji, Akindeh Mbuh; Nash, Denis et al. (2018). Active case finding: comparison of the acceptability, feasibility and effectiveness of targeted versus blanket provider-initiated-testing and counseling of HIV among children and adolescents in Cameroon. BMC Pediatrics, 18 (1), S. 309–309. http://doi.org/10.1186/s12887-018-1276-7.
Kiefer, E. M.; Hoover, D. R.; Shi, Q.; Dusingize, J. C.; Sinayobye, J. D. et al. (2018). Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women. HIV Medicine, 19 (10), S. 734–744. http://doi.org/10.1111/hiv.12665.
Panayidou, Klea; Davies, Mary-Ann; Anderegg, Nanina; Egger, Matthias & IeDEA, COHERE, PHACS and IMPAACT 219C Collaborations Writing Group (2018). Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation. Journal of the International AIDS Society, 21 (11), S. e25200–e25200. http://doi.org/10.1002/jia2.25200.
Kariminia, Azar; Law, Matthew; Davies, Mary‐Ann; Vinikoor, Michael; Wools‐Kaloustian, Kara et al. (2018). Mortality and losses to follow‐up among adolescents living with HIV in the Ie DEA global cohort collaboration. Journal of the International AIDS Society, 21 (12), S. e25215–e25215. http://doi.org/10.1002/jia2.25215.
Zivich, Paul N.; Kawende, Bienvenu; Lapika, Bruno; Behets, Frieda & Yotebieng, Marcel (2018). Effect of Family Planning Counseling After Delivery on Contraceptive Use at 24 Weeks Postpartum in Kinshasa, Democratic Republic of Congo. Maternal and Child Health Journal. http://doi.org/10.1007/s10995-018-2667-y.